integrate report year end december essence management corporate philosophy corporate culture otsukapeople create new product ryukangodo well health worldwide sweat recognize way process keep corporate philosophy otsuka value ryukangodo sweat discover core recognize way jissho actualization sozosei creativity strive substance otsuka otsuka group support live people worldwide wide range hard work innovative creative product include pharmaceutical functional beverage functional practice food dedicate cultivate dynamic corporate culture workplace reflect vision healthcare company find way live harmony local community natural environment contribute rich healthy life jissho actualization selfactualization otsukas goal achievement completion indispensable contributor discovery truth people health worldwide otsuka group aim indispensable contributor people health worldwide fulfil corporate philosophy aspect operation commitment improve people sozosei health worldwide unchanging value continue provide society operation creativity encompass core business pharmaceutical business provide comprehensive health pursue support diagnosis treatment disease nutraceutical business help people otsuka capable maintain improve daytoday health deliver nutraceutical nutrition pharmaceuticalscontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report content otsukas value creation create value fact datum provide value business advance unique total healthcare company financial nonfinancial highlight otsukas goal development pharmaceutical business esg content index total healthcare company nutraceutical business main datum message ceo consumer product business business group structure global network feature corporate information message director charge sustainability year history otsuka group company organization health develop total healthcare company overview main operating company people value creation model disclosure otsuka group quality value creation process generate originality stock information environment otsuka group approach sustainability message outside director materiality material issue message cso message cfo governance corporate governance director audit supervisory board member compliance tax compliance risk management th year symbol zero otsuka q quality quality refer promise guarantee create manufacture deliver product care customer trustcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report provide value business total healthcare company otsuka group contribute people health worldwide create innovative product core business pharmaceutical business aim address unmet medical need nutraceutical business seek fulfill yettobeimagine need consumer unmet medical need diagnosis treatment pharmaceutical business provide value otsuka bring health people worldwide maintain improve daytoday health nutraceutical business yettobeimagine needsotsukas goal development total healthcare company otsuka value creation sustainable society process unmet medical need pharmaceutical business social wellbeing indispensable contributor goal people health worldwide physical wellbee mental wellbee otsukas strength achieve cosmedic cosmetic medicine state health define constitution world health organization ylesolc ot sessenisub gnipoleve seussi laicos sserdda total healthcare ytilairetam content otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report pharma ceutical nutra chemical ceutical otc cosmedic consumer clinical product nutrition medical diagnostic device value creation model create value page page yettobeimagine need nutraceutical business page found present futurecontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report message ceo otsukas centennial otsukas value otsuka group originate establishment continue chemical raw material manufacturer naruto build century tokushima prefecture japan follow year include tough time able progress help overcome challenge adhere concept achieve sustainable espouse generation leader otsuka familyvalue underpin business society relevant today ryukangodo jissho sozosei otsuka ryukangodo sweat recognize way take word otsuka founder busaburo otsuka thing sweat toil discover truth essence instance problem quality magnesium carbonate early day tatsuo higuchi cause considerable frustration head scratch experiment solution discover president representative director ceo coincidencea fortuitous accident otsuka holding co ltd occur everyday endeavor involve way unstinting effort help create bedrock business jissho actualization inspire advice otsuka group company celebrate th anniversary september reach masahito otsuka leader second generation milestone thank support stakeholder include consumer patient medical hypothesize experiment achieve world pharmaceutical drug satisfy percent professional business partner local community requirement regulatory approval drug embark second century offer heartfelt thank reconfirm determination approve like measly otsuka employee pursue otsuka contribute people percent indicator major flaw health worldwide project long long way gocontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report message ceo masahito otsuka say life trump laboratory otsuka challenge persevere pursue truth heart know refer need try group corporate philosophy day creativity matter approach overcome challenge ensure final common byword akihiko otsuka say onepercent gap bridge young decade ago judge hear word think creativity innovation call great creativity strategy stay abreast change surely necessary study innovation bear conviction external risk opportunity attempt later realize worldclass pursue project location observe listen company find challenging result appearance covid pandemic hand truly learn product develop revolutionary product fact lead outsize impact daytoday life factorie consumer react product instore blockbuster like abilify samscajinarcjynarque industrial structure business model consumer prefer particular product naturally creation newcategory product pocari include significant rapid change pharmaceutical need gather fact take action parlay sweat calorie mate industry today face myriad risk fact real awareness understand otsuka leader share common determination opportunity include geopolitical turmoil supply chain sozosei creativity comes akihiko otsuka leader eye task hand appetite disruption rise raw material cost environmental generation sentiment encapsulate hard work usually necessary thing problem population issue evolution artificial slogan otsukapeople create new product thing turn plan intelligence computer technology hard well health worldwide adopt failure lie hint discovery today predict world look like future philosophy otsuka pharmaceutical factorie otsuka group corporate culture encourage people otsuka group indispensable contributor health people worldwide need envision society economy year year ahead agile response anticipate way world ryukangodo jissho sozosei change launch mediumterm sweat recognize way actualization creativity management plan fiscal otsuka group company sit accept fateour process selfactualization pursue discover core achievement otsuka capable style close eye substance completion deliver development adapt flexibly change hard work discovery truth appropriate enable adjust practice transformation bring pandemic pursue business way consistent ourcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report message ceo management plan believe increase popular fiscal middle year medium taking challenge awareness health issue amid new normal term management plan revenue track roughly line believe businesss main driver postcovid era present growth opportunity initial forecast business profit target philosophy culture capability people time demonstrate true result agile approach prioritize investment organization otsuka group corporate philosophy value unique total healthcare company growth redouble effort otsukapeople create new product well health pharmaceutical business achieve push business profit billion yen target worldwide remain universally applicable company revenue target global product set forth fiscal make roic return invest capital solid philosophical backbone strong turbulent mediumterm management plan year ahead conscious investment manage sga expense time remain dedicated seek hard schedule adapt change landscape challenge unafraid change failure lesson carry rd include virtual clinical trial learn pursuit incorporate enhance business continuity plan develop vision year subsequent venture create cycle enhance laborsave technology maintain stable supply capability individual advance ability system manufacturing operate hybrid support stakeholder ground manage organization comprise individual communication system sale combine inperson principle leave generation otsuka family leader otsuka group unique total healthcare digital methodology continue enable otsuka group company thrive company contribute health people worldwide pursue innovation establishment otsuka century observance leader timetase develop provide creative product service pharmaceuticals osaka pharmaceutical research institute wisdom couple flexibility cover diagnosis treatment tentative partnership sumitomo way view carry business disease health maintenance improvement move dainippon pharma sumitomo pharma adapt change market technological forward increase digitalization surely bring major subsidiary sunovion pharmaceutical psychiatry advance respond geopolitical risk change industry drug treatment neurology area hope change operating environment fuse digital technology conventional healthcare nutraceutical business solidify unable time adapt methodology advancement diagnosis presence consumer healthcare market strategy need specific region sustain growth prediction disease strive provider focus global expansion new concept category overcome preconception stereotype comprehensive service product meet specific highprofitmargin product addition strategy energetically incorporate act diverse opinion healthcare need community era sheer emphasize take advantage increase health dare achieve progress spark variety otsuka group business portfolio give consciousness address new need generate innovation seek innovation find foundation need accelerate intragroup cooperation woman play active role workplace insight generate diversity bold action joint venture pursuit unwaveringcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report message ceo furthermore newly define carbon neutrality service business partner circular economy water neutrality environmental stakeholder strive live trust material issue set mediumterm target responsibility invest manufacturer promote nextlevel initiative work address fulfill unmet medical need good accordance recommendation task force partner medical community consumer hope climaterelate financial disclosure advisory board set otsuka group sign comprehensive g financial stability board company partnership agreement prefecture municipality analyze respond risk opportunity bring japan help health climate change maintenance improvement activity support disaster preparation response effort activity possible group position provider stakeholder unique total healthcare ideal opportunity work closely local community find humanity face pandemic time solution challenge face society pandemic major impact time shareholder investor confident wisdom technical innovation overcome continue commitment transparency fairness case covid challenge face management strong governance world find way live virus framework appropriate disclosure accordance otsuka group seek contribute society japans corporate governance code proactive reason exist dialogue continue live trust invest corporate philosophy convince focus company day work hard goal fulfill responsibility society remain contribute people health help usher inspire generation leader otsuka dedicated seek sustained growth generating century sustain growth group sustainability family buoy lofty aspiration steel mediumtolongterm value accordance society unyielde determination corporate philosophy stance help world overcome today patient consumer health sincerely ask continued support guidance environmental problem see conscious pursue stakeholder urge hold high sustainability mission launch business unwavere commitment contribute expectation year otsuka group environmental vision net zero launch people health worldwide new product andcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report life realize hide power feature year history otsuka group develop total healthcare company otsuka group celebrate th anniversary value cultivate long history enable new endeavor business employee world continue create new value people unwavere corporate philosophy otsukapeople create new product well health worldwide photo courtesy tokushima prefectural museumcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report otsukas story billion found chemical raw material manufacturer otsuka group demonstrate outstanding creativity honestly endeavor path believe correct stay true value enable pursue otsuka base valuesryukangodo sweat recognize way jissho actualization sozosei creativitygroup member spur goal unique total healthcare company addition respond change time condition continue contribute people health anticipate future trend develop business leverage uniqueness revenue pharmaceutical business nutraceutical business consumer product business business billion change fiscal year result fiscal month period end december medical cosmedics devices pharma nc ul tin rii tc ioa nl otc cen uu tt ir ls c po rn os du um cte sr nc ul tin rii tc ioa nl ceutical c po rn os du um cte sr cp eh ua tr m caa ls diagnostic c po rn os du um cte sr diagnostic c po rn os du um cte sr pharmd ai agnostic cosme cic os nsumer divb eu rss ii fin ce ts cc g aah gn bm n oi ec naa ais e u ts em f stac rh te em di c ta hls e iv chemi lca al n chn c u el ti dn rii c oa nl nc ul tin rii tc ioa nl ch e mi ls otc nc ul cti enn ri ui uc ta ir cnl ls chemo ict ac ls cen uu tt ir ls chemical otc nc ul tin rii tc ioa cnl en uu tt ir ls chemicalsotc cp eh ua tr nm c c uaa tis n rii tc ioa nl cen uu tt ir ls chemicao lstc ce ncu ut l ti ic n ra ii tcl oa nl cen uu tt ir ls chemical p cduct bo ulu sit nio en sss oronine ointment oronl aa mun inch ce rink launch bon curry establish p h armaceutical estab li sh e launche nn ersignal establish ot u ka medical device otc research institute otsuka assay laboratory otsuka group found aim growth otsuka group grow chemical raw otsuka group begin proactively expand provider wide variety science material manufacturer naruto business overseas maintain back product service city tokushima prefecture improve quality group insist local meet healthcare need time move away singleproduct manufacturing addition provide country region serve manufacture diversify product appropriate price approach group launch new intravenous injection drip create job contribute local medical device business infusion solution communitie otsukapeople create new aiming globalization work pharmaceutical product factory founding era product well health worldwide contract signing ceremony develop ideal approach sell nationwide addition philosophy group china otsuka pharmaceutical age heighten concern pharmaceutical group move food housing domain factorie research institutes otsuka group create new market environment group successfully configure diverse foundation today otsuka group build numerous unique product business diversify business generate value synergy founding era international expansion ss development onwardcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report found era otsuka group begin otsuka seiyaku kogyobu found pharmaceutical food housing otsuka group begin otsuka seiyaku kogyobu otsuka pharmaceutical taiho pharmaceutical otsuka found september busaburo food industry currently otsuka food otsuka otsuka naruto city tokushima prefecture naruto city warehouse group company establish salt pan group japans period rapid economic begin business chemical raw material manufacturer growth addition earth corporation produce magnesium carbonate rubber additive group operate infrastructure grow substantially oronamin c drink bittern byproduct salt production group launch carbonate energy drink oronamin c drink catchphrase genki entrance pharmaceutical business hatsuratsu vitality bear revolutionary nationwide expansion idea create firstever carbonate energy drink complement steady growth chemical raw go group familiar material manufacturer otsuka group enter busaburo otsuka longselling product pharmaceutical business group successively group launch world retort launch new intravenous injection drip infusion pouch food product bon curry develop expertise solution expand business japan cultivate iv solution business bon curry quickly furthermore diversify business widely popular japanese household bon curry technological expertise intravenous injection drip revolutionize mealtime infusion solution chemical product intravenous injection infusion group launch sterilizerdisinfectant oronine ointment solution time iv solution business launch overthecounter otc pharmaceutical establish otsuka seiyaku kogyobu establish taiho pharmaceutical rename otsuka pharmaceutical factory establish otsuka pharmaceutical enter intravenous injection drip launch otsuka food industry currently otsuka food equity infusion solution business oronine ointment investment cbc food industry launch tiovita drink establish otsuka chemical medical product currently otsuka chemical launch oronamin c drink launch oronine ointment launch bon curry establish otsuka warehouse equity investment earth corporation found era international expansion ss development onwardcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report international expansion ss progress internationalization total healthcare internationalization birth pocari sweata replenish drink leverage rise yen dollar develop replenish water electrolyte lose otsuka group begin expand overseas sight set perspiration ion supply drink pocari sweat internationalization begin establishment otsuka group lead product go sale thai otsuka pharmaceutical office palo group decide blue packaging alto group expand europe indonesia product despite color consider taboo color taiwan egypt china today otsuka group soft drink japan time initially receive inauguration ceremony approximately employees work company thai otsuka pharmaceutical positive response result continuous visit country region worldwide december sport venue supermarket public bath sauna similar pocari sweat place communicate importance replenish water inhouse drug discovery electrolyte lose perspiration promote desire create pharmaceutical contribute value product addressing issue pocari sweat global healthcare group establish research enjoy country worldwide institute otsuka pharmaceuticals tokushima factory predominantly japan countries asia begin inhouse drug discovery discover potential carbostyril structure mikelan meptin world art museum housing ceramic group launch inhouse drug beta reproduction major work art blocker mikelan go release bronchodilator march otsuka group mark th anniversary meptin mucosta gastritis gastric ulcer evolve open otsuka museum art inhouse rd production structure process build educational tourism purpose otsuka museum art art museum world house establish thai otsuka pharmaceutical fullsize ceramic reproduction major work art group overseas operate company mucosta world reproduction sistine chapel ceiling open office otsuka museum art launch futraful open office europe establish pt otsuka indonesia launch calorie mate establish taiwan otsuka pharmaceutical establish otsuka pakistan establish arab otsuka pharmaceutical establish otsuka america currently egypt otsuka pharmaceutical establish otsuka america pharmaceutical launch pocari sweat pharmavite join otsuka group launch mikelan meptin launch mucosta establish china otsuka pharmaceutical anticancer drug futraful establish otsuka museum art nutritionally balanced food establish korea otsuka pharmaceutical launch match japan calorie mate establish otsuka pharmaceutical europe found era international expansion ss development onwardcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report development onward true total healthcare company otsuka group continue provide value meet need time country region serve aim help resolve social issue contribution unique otsuka providing value meet new need launch abilifythe world dopamine partial agonist psychiatric recent year addition heighten awareness importance health increase treatmentin otsuka pharmaceutical gone develop sell attention pay environmentally friendly food product otsuka group diverse range unique product service country region move address need product early stage theme social worldwide include samscajinarcjynarque original drug disease contribution daiya food develop manufacture sell plantbase food know treatment meet need diuretic promote product grow result firm support individual strong health awareness excretion water electrolyte loss oncology areaa central new healthrelate value food allergy addition nutrition sant pillar group pharmaceutical businessotsuka pharmaceutical taiho pharmaceutical offer range healthy food include freefrom food product alternative food astex pharmaceutical strategically share unique advanced technology product country worldwide mainly europe japan group sell independently cultivate link technology year expertise variety healthy environmentally friendly product include bon curry veggie series experience otsuka group aim drive sale global product future product contain animalderived ingredient zero meat hamburger product growth aim address unmet need fulfil pharmaceutical japan acquire jas certification soy meat food soyjoy group develop unique medical device combine strength pharmaceutical plantbase series acquire vegan certification use plantbase ingredient clinical development revolutionary technology otsuka group food product contain free specific ingredient example food contain gluten strive growth unrivale total healthcare company glutenfree launch os launch equelle launch abilify launch rexulti launch aminovalue launch bodymaint launch soyjoy launch zero meat gerbl product daiya foods nutrition sant establish otsuka holding launch biomimic launch samscajinarcjynarque japan europe launch soyjoy otsuka holding list section plantbase series soyjoy plantbase series tokyo stock exchange establish otsuka medical device launch abilify maintena launch lonsurf zero meat bon curry veggie found era international expansion ss development onwardcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report challenge new frontier otsuka address unmet need initiative women health market aim generate innovation creative diverse research platform addition exist women empowerment society progress otsuka group seeks create world strength otsuka pharmaceutical cell gene therapie regenerative medicine individual play active role end group focus biologic immune system research advance digital technology highly innovative drug initiative tackle women health issue life discovery field immunology oncology neurodegenerative therapy group provide sciencebacke product equelle dietary supplement effort promote close collaboration information exchange company contain equol support women health beauty time aging bring physical inside outside group otsuka pharmaceutical open osaka mental change tocoelle complex supplement address psychological physical pharmaceutical research institute research hub create value global perspective premenstrual symptom experience woman bup lady otc pharmaceutical japan accredit effective urinary urgency woman group publish womens health health management information usbase uqora specialist provider product urinary healtha particular concern womenhas join otsuka group enable group support woman wide range field group stay closely attune individual need work provide solution women unique health issue image osaka pharmaceutical research institute equelle tocoelle products uqora visterra join otsuka group company proprietary hierotope platform technologies antibody development use entirely different approach conventional method approach otsuka group aim design develop therapeutic antibody drug discovery target bup lady disease consider untreatable group intend provide pharmaceutical address unmet medical need found era international expansion ss development onwardcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report value creation model input outcome provide stakeholder value human capital employee approx japan approx consumer outside japan approx corporate philosophy sustainability mission output value creation process social revenue fiscal relationship capital pharma billion patient total group company ceutical j oa ta sn d e japan chemical cen uu tt ir ls products service pharmaceutical business business site countriesregion therapeutic drug healthcare clinical nutrition product professional unique diagnostic medical device otc cosmedic bring health manufacture capital diverse nutraceutical business people worldwide manufacture site business functional beverage japan foods cosmedic otc shareholder product quasidrug outside japan investors consumer clinical product nutrition consumer product business beverage food alcoholic beverage intellectual capital diagnostic medical device business research site chemical fine chemical employee japan warehouse distribution outside japan sustainability mission packaging electronic equipment total co emission fiscal financial capital tco supplier ryukangodo jissho sozosei total asset billion natural capital local community energy consumption society kl water consumption december reinvestment allocation capital data company include otsuka holding subsidiary affiliate company manufacture site consolidate otsuka groupcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report provide stakeholder value initiative fiscal expand product access contribute resolution unmet need innovation consumer countriesregion antituberculosis drug delamanid available new drug approve patient countriesregion antipsychotic drug abilify maintena sell development project unmet need healthcare professional otsuka pharmaceutical formulate otsuka global patient access support policy research development expense billion july inhouse drug discovery ratio maintain sound financial foundation deliver stable return shareholder shareholder credit rating aa annual dividend share investor de ratio provide new information net cash average monthly consolidated revenue month business briefing institutional investor create vibrant workplace environment enhance employee engagement group company recognize certify health productivity female manager ratio otsuka holding management outstanding organization meti employee employee take parental leave group company enhance measure respect human right male employee take parental leave total formulate implement otsuka group human right policy march offer necessary training promote sustainable procurement company attend supplier briefing supplier supplier implement selfassessment questionnaire saq interview hold supplier enhance system realization healthy lifestyle reassess use raw material execute cooperation agreement prefecture japan promotion launch pet bottle recycled material local collaboration health awareness activitie otsuka pharmaceutical environmental management community provide support covid pandemic formulate environmental vision net zero society donate relief good fund revise mediumterm goal target material issue increase utilization renewable energy announce support recommendation task force climate reduction co emission adoption renewable energy tco relate financial disclosure tcfd carry scenario analyse quick navi flucovid ag otsuka minor bcrabl mrna measurement kit ajovy moizerto domestic otsuka holding otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical otsuka warehouse unmet need area define otsuka base patientsmapjp patientsmapus ssri otsuka chemical otsuka food otsuka medical device otsuka electronic otsuka techno okayama taiho pharmaceutical inhouse drug discovery ratio latephase development project phase onward otsuka packaging industry otsuka ohmi ceramics higashiyama film otsuka wellness vend jimro overseas otsuka pharmaceutical development commercialization otsuka america pharmaceutical pharmavite rating investment information inc otsuka holding otsuka pharmaceutical taiho pharmaceutical earth corporation otsuka pharmaceutical factory otsuka net cash cash cash equivalent borrowing bond pharmaceutical health insurance association otsuka medical device otsuka wellness vend otsuka electronic jimro briefing tuberculosis initiative briefing daiya business institutional investor brief pharmavite business institutional investor briefing material visit httpswwwotsukacomenirlibrarybriefinghtmlcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report value creation process generate originality take challenge otsuka originality otsuka generate combination unique diverse business attempt create new value unique stand total healthcare company involve diverse business new original value product utilize link business service create new domain diverse business exist business otsuka group boast wealth human resource diverse expertise experience enter exist market accumulate technological create new market scientific asset company think pharma ceutical nutra diversify need chemical ceutical change bring time environmental change unique otc cosmedic change healthrelate notion diverse anticipate needs arise change business consumer clinical product nutrition medical diagnostic devicescontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report value creation process generate originality otsuka otsukas strength people source strength otsukas establishment employee pursue business guide endure corporate philosophy order bring health people worldwide determination develop strength strength describe representative sample otsuka group employee utilize strength work maximize effect contribute health people world endure corporate philosophy essence management unwavere quest originality ability nurture endure brand passed practice group topshare product pharmaceutical category inhouse drug discovery ratio countriesregion japan outside japan corporate philosophy display prominently development project office country region unmet need project eh xpar ee r io enf cc eo n os fu um sie nr gs w poit ch rh ie weat business communication corporate philosophy continue challenge revolutionary develop product brand tenaciously essence management otsuka employee product service strive creativity value communicate value revolutionary product world work otsuka contribute chain look opportunity unique aim sustainable growth health people worldwide otsuka innovation enhancement corporate value inhouse drug discovery ratio latephase development project copyright iqvia create base annual category total phase onward past year include iqvia midas otsuka research december unmet need area define otsuka base category define otsuka reprint permission patientsmapjp patientsmapus ssri november survey japan conduct otsuka business model center global reach incorporate solution social solid financial foundation strong total healthcare issue core business process earning power drive sustainable growth iv solution business overseas company aa social wellbeing rating physical wellbeing countriesregion mental wellbee pocari sweat available b nu ti rn ae cs es u p tir co af l bt um sa inrg esin f countriesregion antituberculosis contribute aspect health drug delamanid available provide variety sciencebase product service extend global reach address social cultivate solid financial foundation strong meet specific healthcare need time issue differ countryregion depend earning power nutraceutical iv solution community culture custom time generate stable earning act base therapeutic agent driver growth fund number company engage iv solution business company export product neighboring country ongoe investment creative new area befit otsuka make meaningful contribution medical care country rate investment information inc average previous year reference average operating profit margin sp food beverage select industry index constituent previous year otsuka group determine material issue society health people quality environment carbon neutrality circular economy water neutrality governance work group achieve goal sustainability mission address social issue evolution healthy sustainable society simultaneously achieve growth activity support comprehensive governance system contribution sustainable society map social issue compile list social issue relevant otsuka group business create map social issue consider importance term sustainability degree otsukas business fully synchronize effort address social issue impact business activity high environment healthy planet society healthy society carbon neutrality circular economy health people quality water neutrality global warming spread infectious disease governance risk stem corporate governance compliance risk management social change lack response consumption production diversification impairs sustainability increase environmental impact fragile governance system presenteeism degree impact business activity high ytilibaniatsus ot drager htiw ecnatropmi content otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report create future value lead originality otsuka group approach sustainability identification social issue reference respective international guideline assessment social issue business activity contribute solve importance determination material issue sustainability promotion committee viewpoint impact society otsuka group approval otsuka holding board director meet sustainability promotion committee promote sustainability otsuka group committee responsibility include discuss decide direction plan sustainability activity otsuka holding director charge sustainability promotion serve committee chair committee member comprise group manager department relate sustainability sustainability officer company increase issue cause population age nutritional need unmet medical health need reduce freshwater availability water process determine materiality material issue resource risk materiality initiative otsuka focus determine otsuka group material issue compile list social issue reference range international guideline framework include iso gri un sdgs narrow list issue evaluate term importance take account ability contribute solution impact business strength issue discuss sustainability promotion committee approve otsuka holding board director meet issue bold priority social issue situation despite come work productivity increase employee poor mental physical conditioncontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report otsuka group approach sustainability relationship materiality mediumterm management plan description materiality description mtm plan corporate philosophy sustainability mission longterm fy goal contribute challenge new frontier promotion rd unmet need resolution unmet need otsuka address unmet need psychiatry neurology area health create firstinclass product cardiovascular renal area area unmet need generate innovation creative new development project diverse research platform latephase development project advance phase eradication tuberculosis provide delamanid case supply deltyba generic delamanid pediatric patient launch clinical trial new treatment regiman increase access delamanid collaborate partner creation system challenge new category create new system reinforce exist realization healthy lifestyle new area system realization healthy lifestyle create new concept product keep healthy life extension maintain highprofit structure eye change environment health people quality carbon neutrality circular economy water neutrality governancecontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report materiality material issue social materiality social issue goal activity relate sdgs fy goal fy progress issue promotion rd unmet need area unmet need address unmet need psychiatry neurology area new development project project create firstinclass product oncology area latephase development project advance phase project create firstinclass product cardiovascular renal area area unmet need new development project promotion rd unmet need latephase development project advance phase unmet medical health need contribution resolution unmet need rd antitubeculosis drug improvement drug access provide delamanid case provide delamanid case ahead schedule countriesregion continue participation pantb collaboration accelerate development health nsp ur te ra d io nf ln nf ee ect dio sus disease e cr ra ed ai tc ioa nti f ao f ytu stb ee mrc fu olo r ti hs e realization hu ep alp tho r mt ind ea nw aa nr ce en e imss p roc vti ev miti ee ns tf mr p ae ino lyp l oe ns lau np cly h e cl light ny icb ala tr iag le fn oe rr nc e n wa tree td mel ea nm ren gid m f eo nr pediatric patient dee tl et rmyb ina ed tp op cro ov ne dd u cfo r c lp ine d ci aa lt tr ric ia p l foti nn ets w n ru er eo p de ru gn co oc mto bb ine ar io n therapy regiman include df e n lae mw nb d r se ua pt pm lie en dt tr rg oi um ge hn global drug facility gdf stop tb increase issue cause healthy lifestyle exercise nutrition etc increase access delamanid collaborate partner opc delamanid partnership alliance partner population age healthy life extension promotion problem solve strengthen continue participation global health innovative technology fund ghit fund partnership challenge new category new area execute comprehensive cooperation agreement health prefecture japan ongoing provision kenko shacho healthy president service create new system reinforce exist system realization local government promote collaboration health field expand dietary education communicate importance good nutrition society healthy lifestyle raise awareness proper hydration electrolyte replenishment support disaster emergency healthy create new concept product keep eye change continue hold women health seminar support tokyo marathon society environment year publish otsuka health comic library support interhigh school championship cumulative total oathas registrant approximately instill corporate culture philosophy cumulative total participant executive human resource development program otsuka global total number attendee groupwide diversity seminar human resource development build system ongoing human resource development align academy oga implement otsuka group human right policy offer necessary training presenteeism creation corporate culture stimulate creativity people diversity promotion change society time cumulative total participant health seminar approximately lack response diversification enhance employee engagement health productivity management promote instill diversity source innovation build new system maintain comfortable working environment sustainable procurement product design supplier implement selfassessment questionnaire saq cumulative total company implement saq hold global product quality meeting gain stakeholder trust thorough quality control stable supply pursue sustainability level value chain cumulative total company participate supplier briefing formulate nc global quality policy quality consumption production pursue sustainability level value chain r esponsible promotional activity information provision sustainable procurement stable supply product covid pandemic improve product base customer feedback impairs sustainability establish quality assurance system safety deepen communication stakeholder conduct supplier briefing supplier hold global production meeting manufacturing error workshop environmental security promotion consumeroriente management original goal timescompanie fiscal management information exchange meeting c na er ub ran l ity global warming arget reduce co emission compare reduce co emission value chain e r ne ed ru gc ye ec ffo ic ee nm cyission introduce renewable energy maximizing tn cn fo du n ac ne dd cs au rp rp ieo dr f uo tr rt ih ske nc ao lym sem sendation task force climaterelate financial disclosure cn os mta pll le ed ec ing te rn oe dr ua ct tio ion n oy f ce om fa ren ed efu lee cl c rio cn itv ye r tio e q u dp om en st tic factory reduce co emission value chain group company target reduce simple incineration reduce environmental impact improve reduce environmental impact enhance resource efficiency begin sale pet bottle recycled pet resin circular landfill disposal compare resource efficiency promote business activity aim social environmental environmental load increase economy target content recycle plant promotion business activity aim sustainability environment base material pet bottle sustainability society earth healthy target expand plant water management analyze ascertain risk sustainable water usage formulate plan create water resource management program planet water reduce freshwater availability program location globally understand water resource risk ensure effective use management water resource neutrality water resource risk target develop water use strategy management effective use water resource business location waterstresse area build system strengthen compliance group carry activity director raise effectiveness reinforce effort improve efficacy crisis management strengthen corporate governance fragile governance system strengthen corporate governance raise effectiveness board director meet attendance rate reinforce response overseas risk governance longterm improvement corporate value thorough compliance social change risk build governance system capable global business development implement otsuka group global antifraud policy improve level information security group company risk identification evaluation management response change launch basic cyber security training program situation despite come work productivity increase employee poor mental physical condition sustainable energy use sustainable use raw material sustainable use water resourcescontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report fiscal goal fiscal progress social issue determine otsuka group materiality select issue regard especially important present set goal relate fiscal social materiality social issue goal activity relate sdgs fy goal fy progress issue promotion rd unmet need area unmet need address unmet need psychiatry neurology area new development project project create firstinclass product oncology area latephase development project advance phase project create firstinclass product cardiovascular renal area area unmet need new development project promotion rd unmet need latephase development project advance phase unmet medical health need contribution resolution unmet need rd antitubeculosis drug improvement drug access provide delamanid case provide delamanid case ahead schedule countriesregion c ontinue participation pantb collaboration accelerate development health n sp ur te ra d io nf ln nf ee ect dio sus disease e cr ra ed ai tc ioa nti f ao f ytu stb ee mrc fu olo r ti hs e realization hu ep alp tho r mt ind ea nw aa nr ce en e imss p roc vti ev miti ee ns tf mr p ae ino lyp l oe ns lau np cly h e cl light ny icb ala tr iag le fn oe rr nc e n wa tree td mel ea nm ren gid m f eo nr pediatric patient dee tl et rmyb ina ed tp op cro ov ne dd u cfo r c lp ine d ci aa lt tr ric ia p l foti nn ets w n ru er eo p de ru gn co oc mto bb ine ar io n therapy regiman include f e n lae mw nb d r se ua pt pm lie en dt tr rg oi um ge hn global drug facility gdf stop tb increase issue cause healthy lifestyle exercise nutrition etc increase access delamanid collaborate partner opc delamanid partnership alliance partner population age healthy life extension promotion problem solve strengthen continue participation global health innovative technology fund ghit fund partnership challenge new category new area execute comprehensive cooperation agreement health prefecture japan ongoing provision kenko shacho healthy president service create new system reinforce exist system realization local government promote collaboration health field expand dietary education communicate importance good nutrition society healthy lifestyle raise awareness proper hydration electrolyte replenishment support disaster emergency healthy create new concept product keep eye change continue hold women health seminar support tokyo marathon society environment year publish otsuka health comic library support interhigh school championship cumulative total oathas registrant approximately instill corporate culture philosophy cumulative total participant executive human resource development program otsuka global total number attendee groupwide diversity seminar human resource development build system ongoing human resource development align academy oga implement otsuka group human right policy offer necessary training p resenteeism creation corporate culture stimulate creativity people diversity promotion change society time cumulative total participant health seminar approximately lack response diversification enhance employee engagement health productivity management promote instill diversity source innovation build new system maintain comfortable working environment sustainable procurement product design supplier implement selfassessment questionnaire saq cumulative total company implement saq hold global product quality meeting gain stakeholder trust thorough quality control stable supply pursue sustainability level value chain cumulative total company participate supplier briefing formulate nc global quality policy quality consumption production pursue sustainability level value chain r esponsible promotional activity information provision sustainable procurement stable supply product covid pandemic improve product base customer feedback impairs sustainability establish quality assurance system safety deepen communication stakeholder conduct supplier briefing supplier hold global production meeting manufacturing error workshop environmental security promotion consumeroriente management original goal timescompanie fiscal management information exchange meeting c na er ub ran l ity global warming arget reduce co emission compare reduce co emission value chain e r ne ed ru gc ye ec ffo ic ee nm cyission introduce renewable energy maximizing tn cn fo du n ac ne dd cs au rp rp ieo dr f uo tr rt ih ske nc ao lym sem sendation task force climaterelate financial disclosure cn os mta pll le ed ec ing te rn oe dr ua ct tio ion n oy f ce om fa ren ed efu lee cl c rio cn itv ye r tio e q u dp om en st tic factory reduce co emission value chain group company target reduce simple incineration reduce environmental impact improve reduce environmental impact enhance resource efficiency begin sale pet bottle recycled pet resin circular landfill disposal compare resource efficiency promote business activity aim social environmental environmental load increase economy target content recycle plant promotion business activity aim sustainability environment base material pet bottle sustainability society earth healthy target expand plant water management analyze ascertain risk sustainable water usage formulate plan create water resource management program planet water reduce freshwater availability program location globally understand water resource risk ensure effective use management water resource neutrality water resource risk target develop water use strategy management effective use water resource business location waterstresse area build system strengthen compliance group carry activity director raise effectiveness reinforce effort improve efficacy crisis management strengthen corporate governance fragile governance system strengthen corporate governance raise effectiveness board director meet attendance rate reinforce response overseas risk governance longterm improvement corporate value thorough compliance social change risk build governance system capable global business development implement otsuka group global antifraud policy improve level information security group company risk identification evaluation management response change launch basic cyber security training program cumulative total cumulative total otsuka advanced training healthy age supporter program support pharmacie health information include carbonneutral electricity utilize certificate equal renewable energy emit co hub strong connection local community otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical otsuka chemical otsuka food december content otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report message cfo brand nutraceutical business overcome loss revenue expiration major copromotion agreement business profit billion yen practice business decrease billion yen previous year solid management awareness growth exist business outweigh capital cost pursue increase expense onetime factor early sustainable growth deployment investment growth roe roic enhance corporate value initial target middle year maximize business value mediumterm management plan billion yen make investment growth revenue billion yen business profit roe higher exclude aforementione expense onetime factor revenue target business profit target roe target yuko makino result mediumterm management plan executive director cfo otsuka holdings co ltd fiscal target revenue billion business profit billion cagr roe high progress mediumterm progress middle year fiscal billion management plan mediumterm management plan fiscal business impact variety event overview plan covid pandemic soar raw material price period mediumterm management plan supply chain disruption able positioned fiveyear growth phase advance overcome issue harness strength global market unique total healthcare company conduct broadranging business unique total oorr hhiigghheerr wh ee wph ila l r mm aa xc imeu izti ec el x b isu tis nin ge bss u sa nd es sh n luu et r aa nc de u ct ri ec aa tl e b nu esi wne ss hea wlth ec ar ce h c ieo vm edp rn ey v enue billion yen year high value conduct business management corporate increase billion yen previous year wide awareness capital cost maintain mainly increase billion yen revenue e e sustainable growth time make global product pharmaceutical revenue business profit cagr roe investment growth ensure return shareholder business major brand nurture announce february announce content otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report message cfo variety risksinclude relate pursue progress target line creation core business pharmaceutical geopolitic interest rate exchange rate fluctuation mediumterm management plan nutraceutical conscious capital cost continue unpredictable operating business operation commitment lead maximize environment fiscal cash return exist business allocate generate close eye potential impact business measure enhance corporate value cash reinvest future growth area appropriately respond flexibly timely manner meet target make stable ongoing shareholder return mediumterm management plan maximize exist business value mediumterm management plan roic management work implement corporatewide awareness capital plan fiscal aim mediumterm management plan cost set weight average cost upfront investment period embe commitment group focus capital wacc benchmark otsuka group include fiscal foresee growth maximization exist business value new value focus embed roic management global product mediumterm management plan order secure framework financial strategy pharmaceutical business stable return business activity excess cost pocari sweat capital addition pursue maximization revenue supplement return excess cost capital aim achieve well cost management improve nutraceutical business business management tailor business product roic wacc fiscal efficient asset liability management forecast revenue closely align balance sheetone major billion yen yearonyear cash flow generation cash allocation factor roic management thoroughly implement increase billion yen approach lead high cash return business forecast business profit business investment specific measure aim establish roic management profit growth billion yen yearonyear operating reinvestment outline cash flow increase billion yen improvement capital lead ongoing growth ccc expenditure maximizing revenue exist business exist business maximize revenue core business increase revenue new debt financing dividend pharmaceutical business nutraceutical shareholder product launch forecast return business pharmaceutical business reduction share buyback roe yearonyear nonoperate asset year ahead schedule achieve final year increase point revenue target global product roic yearonyear mediumterm management plan nutraceutical external debt shareholder equity increase point business aim fast growth optimal capital structure major expansion major brand well conveying value provide nurture cash conversion cycle brand supplement business particular high optimal mix external borrowing shareholder equitymessage cfo level health consciousness great trust structure encompass operation multiple financing perspective stabilize brand quality generating revenue growth regionsjapan north america europe asia china financial base improve capital efficiency reduce look expand share service strengthen interestbeare debt external financing require cost efficiency exist business platform promote intragroup financing casebycase basis base comprehensive launch pharmaceutical product set optimize procurement function example assessment cost time require access sell general administrative sga expense ratio intragroup financing adoption cash management fund balance term debttoequity ratio target seek efficient use cost system region system lead efficient metric credit rating way ensure optimal carefully control expense goal sga funding otsuka group company region balance interestbeare debt shareholder expense ratio final year mediumterm reduce need external borrowing reduce interest equity capital structure management plan approximately aim payment contribute ability generate cash embed thorough roic management groupwide achieve ahead time improve shortterm capital efficiency nutraceutical business amid aggressive corporate department initiative region mediumtolongterm corporate value investment competitor strive efficient financial standpoint build stable financial base initiative region discipline control cost unique method order continue otsuka communicating product value japan establish otsuka business support standardization efficiency initiative human resource accounting roic management invest capital perspective north standardization efficiency initiative human resources america procurement finance center otsuka america invest capital operating approach establish otsuka holding europe germany begin europe standardization efficiency initiative work process operating liability invest work capital etc capital finance asia standardization share initiative finance work process operating asset approach china efficiency initiative human resource finance audit work capital interest financing compliance work process center otsuka china investment fix asset etc bear debt borrowing bond cost debt close eye balance sheet interest payment look invest capital asset perspective emphasize efficient management operating asset shareholder creditor nonoperate equity strive maintain appropriate inventory level control asset cost equity work capital strengthen management fix asset expect return corporate department initiative periodically review share hold business strategic corporate department support cost efficiency purpose continue address issue return excess optimal capital indirect department smooth business operation nonoperate asset include idle fix asset cost capital structure enhance business foundation groupwide find way effective use strengthen governance management business sell increase mediumtolongterm corporate value stnemtsevni srotsevni content otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report sga expense ratio pharmaceutical product market approx approx approx aa e e year average mediumterm management plan actual result fiscal plancontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report message cfo business profit pharmaceutical base turn help contribute society pave impend patent expiration second medium nutraceutical business way innovation term management plan period fund investment billion organic growth nutraceutical business framework financial strategy support business segment pharmaceutical business pharmaceutical new value creation direct fund ongoing investment rd aim business source fund investment growth enhance product pipeline core area principle investment growth fund psychiatry neurology area oncology area reinvestment cash return generate business cardiovascular renal area addition investment effective use fund cash target create new value meet unmet medical need nutraceutical management system establish otsuka group include disease exist therapeutic drug new business europe north america japan external concept integrate drug digital technology procurement cash require prepare abilify mycite medical device apply new implement range option include commercial approach ultrasound renal denervation treatment second mediumterm mediumterm management plan management plan paper corporate bond bank loan share issue refining manufacturing technology enhance product select optimal approach account quality implement rationalization measure clinical factor credit rating financial security cost nutrition business achieve stable cash generation businesss steady generation profit enable time require ensure ability act japanese market link success overseas growth group sustain stable growth timely manner business opportunity arise market allocate fund business area regional market shareholder return policy allocation fund growth investment nutraceutical business reallocate cash basic policy shareholder return maintain stable otsuka group investment vehicle earn major brand creation new dividend emphasize continuity stability pursue innovation enable contribute society category expand new region build dividend carefully consider dividend continue pursue investment potential brand strengthen manufacture marketing comprehensively weigh issue appropriate level increase corporate value social contribution structure nurture brand make proactive retain cash investment growth maintain solid reallocating fund investment position continue investment well convey value product financial standing achieve optimal capital structure fund need necessarily allocate aggressive investment pharmaceutical core tenet financial strategy original portfolio segment specific business nutraceutical business establish continued issue stable dividend medium product region pharmaceutical business structure business term management plan period despite shortterm nutraceutical business different segment inseparablelike wheel cartbut capable fluctuation performance move forward consider help cash investment support term revenue profit shareholder return depend circumstance instance abilify generate largescale revenue period mediumterm management include outlook investment growth cash abilify diversify plan pharmaceutical business susceptible target increase profit subsequent mediumterm pharmaceutical businesss revenue structure promote up down revenue profit factor management plan group overall financial situation globalization business avert risk expiration exclusive license nutraceuticalcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report create value advance unique total healthcare company progress mediumterm management plan comprehensive provider diverse range sciencebase product service otsuka group growth underpin dedication overview fiscal address healthcare need accordance time characteristic fiscal year mediumterm management plan see ongoing social community serve social issue face country region differ uncertainty covid pandemic impact otsuka group depend local culture custom constantly evolve identify business activity despite restriction sale activity reduce consumption help resolve change social issue continue expand globally take heighten health awareness growth opportunity leverage true value devoted supply product service help country unique total healthcare company result maintain solid growth achieve revenue region overcome challenge billion yen increase previous year business strategy revenue business segment exist business value maximization new value creation strengthen strategic initiative growth driver global product pharmaceutical business major brand nurture brand nutraceutical business fy pharmaceutical business l aunch nurture new driver sustainable growth pharmaceutical nutraceutical business nutraceutical business consumer product business billion business performance target business profit cagr organic growth mainstay product brand pharmaceutical nutraceutical business ctively invest rd continue create new drug drive revenue outcome progress mediumterm management plan total healthcare company disseminate provide new value unique total healthcare company response new social issue cause pandemic revenue billion adapt environmental change tailor mediumterm management plan mediumterm result management plan target business profit billion cagr fiscal result progress line mediumterm management plan target fy pharmaceutical global product sale achieve mediumterm management plan target year roe higher ahead schedule nutraceutical profitability reach high japanese food sector growth strategy strengthen pipeline psychiatry neurology area enrich pipeline japan business nutraceutical new category women health plantbase food achieve nature target billionyenbrandcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report advance unique total healthcare company otsuka group materiality set specific goal healthrelate social issue unmet medical health need spread infectious disease nutritional need mediumterm management plan end fiscal make progress meeting goal social issue unmet medical health need spread infectious disease nutritional need goal contribute resolution unmet need eradication tuberculosis creation system realization healthy lifestyle promotion rd unmet need address unmet need psychiatry neurology area create firstinclass product oncology area provide delamanid case challenge new category new area create firstinclass product cardiovascular renal area supply deltyba generic delamanid pediatric patient create new system reinforce exist system realization fy goal healthy lifestyle area unmet need launch clinical trial new treatment regimen create new concept product keep eye change new development project increase access delamanid collaborate partner environment latephase development project advance phase execute cooperation agreement health prefecture japan local government promote collaboration provide delamanid case ahead schedule health field countriesregion raise awareness proper hydration electrolyte replenishment deltyba approve pediatric patient europe october continue hold women health seminar area unmet need et ar pm yi n ree gd mto e nco tn hd au c int cc uin di eca l tr pia cl f r n e w ah nre de dd er lau mg ac m dbination year publish otsuka health comic library fy progress new development project project continue participation pantb collaboration accelerate cumulative total oathas registrant approximately latephase development project advance phase development new tb treatment regiman ongoing provision kenko shacho healthy president service project delamanid supply global drug facility gdf expand dietary education communicate importance good stop tb partnership alliance partner nutrition continue participation global health innovative support disaster emergency technology fund ghit fund support tokyo marathon support interhigh school championship unmet need area define otsuka base patientsmapjp patientsmapus ssri cumulative total content otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report advance unique total healthcare company pharmaceutical business mediumterm management plan call begin new development project project progress mediumterm management plan maximize exist business value challenge new frontier fiscal advanced latephase development otsuka generate project phase project fiscal billion innovation creative diverse research platform unmet need area define otsuka base patientsmapjp advantage strategic framework position patientsmapus ssri global productsabilify maintena rexulti progress global product samscajinarcjynarque lonsurfas growth global product expand region add driver focus increase revenue indication overseas work increase awareness global product continue develop business convenient dosage formulation drug revenue work achieve plan target billion yen fiscal rise previous year billion revenue fiscal yen achieve billion yen target medium e e otsuka group focus unmet medical health term management plan year ahead schedule rd mtm plan need social issue fiscal unmet need area global product pharmaceutical business growth future fy fy fy billion yearonyear growth rate revenue revenue revenue plan abilify maintena rexulti samscajinarcjynarque lonsurf total abilify maintena rexulti aripiprazole antipsychotic longacte injectable brexpiprazole atypical antipsychotic global treatment schizophrenia increase awareness drug efficacy claim market adjuvant treatment major depressive disorder treatment schizophrenia convenient dosage formulation follow approval additional indication drug highly evaluated efficacy safety new treatment option treatment bipolar disorder prescription increase prescription increase disease japan drug market treatment schizophrenia begin sale japan follow approval additional indication treatment bipolar disorder orally disintegrate tablet november europe sale begin april september present clinical trial way aim contribute treat unmet need psychiatry neurology areacontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report advance unique total healthcare company samscajinarcjynarque lonsurf tolvaptan vreceptor antagonist trifluridinetipiracil anticancer agent samsca highly evaluate guideline japan prescription increase lonsurf treatment option unresectable advanced recurrent colorectal cancer treatment cardiac edema hepatic edema prescription treatment autosomal december approve country region prescription increase dominant polycystic kidney disease adpkd intractable renal disease increase owe furthermore combination therapy bevacizumab list recommend treatment promotion proper use guideline disease awareness activity drug option national comprehensive cancer network nccn guideline colon cancer contribute resolve unmet need follow approval additional indication january rectal cancer december japanese society cancer syndrome inappropriate antidiuretic hormone secretion siadh june colon rectum jsccr guideline january treatment jynarque launch treatment adpkd effort raise option metastatic gastric cancer number country region lonsurf disease awareness clinical trial datum available helped spread recognition approve total number prescription increase maximize disease drug lead steady increase prescription europe jinarc sell value currently conduct clinical study develop well combination therapy approximately country number patient receive treatment drug national comprehensive cancer network nonprofit alliance lead cancer center increase devoted patient care research education global operation adpkd drug role lonsurf medical setting lonsurf thirdline subsequent chemotherapy option patient colorectal gastric cancer addition efficacy oral agent believe provide additional value convenience enable patient spend time receive treatment time outside medical facility launch approx contribute approx important field oncology support treatment chisato mashita country patient specialist frontline work closely assistant section identify patient need pandemic manager difficult gather communicate information medical yokohama sale setting otsuka group enhance cooperative framework contribute approx branch ethical drug patient sale section mean include share information group taiho pharmaceutical company otsuka group utilize unique group synergy aim quickly carefully communicate essential information improve quality life patient family estimate number adpkd patient europe japan december inhouse surveycontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report advance unique total healthcare company future pharmaceutical business opportunity risk future initiative disruption cause global conflict factor risk affect pharmaceutical business include backdrop addition work reduce risk pharmaceutical business taking challenge relate reduced visit medical institution delay reinforce supply chain ensure stable product new area utilize unique quality clinical development global covid pandemic suppliesthe otsuka group contribute resolution otsuka group work address unmet need generate paradigm shift treatment cause advance digital social issue initiative target disease innovation creative diverse research platform technology medical cost inflation supply chain unmet need work develop systematic solution optimize medical care furthermore form alliance promote open innovation work venture capital firm reinforce drug discovery foundation diversify modality strength weakness seek strengthen supply chain secure backup provide total healthcare solution diagnosis treatment delay register trial participant specific problem global rd marketing asset psychiatry neurology field psychiatry neurology cause spread supplier enhance accuracy sale forecast area renal area covid promote development marketing activity use digital presence oncology area patent expiration mainstay product technology stable profit iv solution business dependence manufacture site raw material supplier medical technique digital technology production contractor concentrate specific region addition strive improve profitability originality free fix idea trength w eakness maximizing value exist product carry trial new project actively invest second mediumterm management plan develop new opportunity threat product aim grow pipeline advance science technology progress basic global drug price control policy promotion generic drug drive development onward achieve research relate disease use medical cost inflation creation synergy therapeutic drug advance intensify competition core area sustainable growth digital technology pandemic relate spread infectious disease promotion precision medicoine enhance efficacy supply chain disruption geopolitical riskts factor pportunity hreatcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report advance unique total healthcare company psychiatry neurology oncology aiming topclass global player psychiatry neurology maximize business value proprietary drug discovery platform area highpotential pipeline product portfolio initiative new drug discovery technology methodology psychiatric disease schizophrenia bipolar disorder major depressive disorder taiho pharmaceutical broad product portfolio support proprietary drug discovery develop age affect person social life career study platform technology include biochemical modulation technology continue concern increase alzheimer disease world population age disease develop history cysteinomix drug discovery platform enable specific affect patient quality life place strain family member covalent modification therapeutic target fragmentbase drug discovery platform caregiver healthcare economy psychiatric neurological establish astex pharmaceutical example futibatinib discover disease satisfactory treatment establish cause cysteinomix drug discovery platform grant breakthrough therapy designation mechanism fully understand make discovery new drug extremely fda march fda accept new drug application futibatinib difficult otsuka group enter psychiatry neurology area priority review likewise pimitespib approve japans ministry health labour continue challenge new drug discovery goal contribute welfare indication gastrointestinal stromal tumor progress medical need chemotherapy taiho pharmaceutical accelerate drug development resolve unmet otsuka group develop extensive highpotential pipeline need collaborate partner company furthermore look opportunity product lineup application small molecule large molecule compound collaboration promise startup corporate venture capital expand technology digital technology aim topclass global player development pipeline cancer immunotherapy area acquire innovative drug psychiatry neurology area discovery platform technology center external collaboration otsuka pharmaceutical taking challenge establish new therapy focus future include create synergies agitation associate dementia alzheimer type new modality area genemodifie cell therapy estimate approximately million people estimate individual group company combine accumulate asset field strength alzheimer disease think large number patient exhibit bolster global operation enhance business value form behavioral disorder agitation excessive motor activity verbal p latform discover compound specifically form covalent bond reactive amino acid residue mainly cysteine physical aggression kind disorder place burden patient caregiver residue protein potential drug target protein impact quality life otsuka group aim market world treatment echnology create new compound molecular design clarifie interaction smallmolecular fragment show pharmacological activity measure highthroughput screen large molecule protein agitation associate dementia alzheimer type clinical trial way complicated structure implicate disease potential drug target drug different mechanism action brexpiprazole avp hope therapeutic development project contribute physical wellbeing patient mental wellbee social wellbeing include caregiver solution realization sustainable society drdecision resource llc right reserve reproduction distribution transmission publication prohibitedcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report advance unique total healthcare company cardiovascular renal system antituberculosis drug research development create firstinclass product new drug discovery technology delamanid improve global health new drug year medical device otsuka cardiovascular renal area addition strengthen proprietary drug discovery delamanid new antituberculosis drug approve world past platform plan actively growth investment example include year mdrtb currently gain prominent attention think tb business alliance aurinia pharmaceuticals voclosporin acquisition visterra disease humankind overcome rifampicin currently company renal diseaserelate pipeline combine expertise pharmaceutical firstline drug discover researcher medical device technology develop medical device minimally invasive research institute world stop development otsuka pharmaceutical continue impactful body launch biomimic vascular stent system japan research base belief tb global health problem continue ultrasound renal denervation system revolutionary treatment method patient research delamanid create year otsuka high blood pressure exist treatment prove ineffective grant pharmaceutical remain actively engage rd new antituberculosis drug breakthrough device designation fda treatment bear ce mark europe decade company consistently rank funder tb rd worldwide clinical trial way japan move forward aim provide firstinclass product innovative approach nextgeneration tuberculosis drug candidate opc display product conform relevant health safety environmental protection standard specify otsuka pharmaceutical conduct research antituberculosis drug follow eu legislation delamanid late development compound call opc undergo phase ii trial south africa confirm safety efficacy opc kill tb focus building otsuka kidney franchise bacteria mechanism inhibit activity enzyme essential join otsuka visterra endeavor grow synthesize mycobacterium tuberculosis cell wall mechanism action differ capability biologicsbase drug discovery accelerate completely exist antituberculosis drug include delamanid expect medicine clinical testing continue develop stateof effective treatment strain tb develop drug receive grant theart machine learning algorithm expedite workflow bill melinda gates foundation cite elimination tb worldwide employ innovative scientific strategy create novel priority advance clinical trial continue engage tb rd aim antibodybase design successful collaboration medical team establish innovative treatment method zachary shriver visterra otsuka continue advance investigational chief scientific officer medicine challenge present covid pandemic collective effort lead noteworthy visterra success sibeprenlimab vis progress rapidly phase iii clinical trial treatment iga nephropathy autoimmune disease kidney recently award orphan drug designation european medicine agency addition vis drug intend regulate autoimmune response recently grant regulatory permission initiate clinical trial give recent success look forward continue collaboration expand otsukas franchise nephrology immunologycontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report advance unique total healthcare company major development progress product indication countryregion progress psychiatry neurology brexpiprazole schizophrenia pediatric patient approve fremanezumab migraine japan approve aripiprazole longacte injectable schizophrenia china file centanafadine smoking cessation start phase ii implement phase iii ulotaront schizophrenia japan implement phase iiiii sep bipolar depression japanus implement phase iii oncology pimitespib gastrointestinal stromal tumor japan file fosnetupitant chemotherapyinduce nausea vomit japan file cholangiocarcinoma japanuseurope start phase iii futibatinib urothelial cancer europe start phase ii ta solid tumor harbor germline pten inactivate mutation japanuseurope start phase ii astx acute myeloid leukemia start phase ii opc multiple myeloma japan start phase iii tas acute myeloid leukemia start phase cardiovascular renal system opc cardiac edema japan file voclosporin lupus nephritis europe file bempedoic acid hypercholesterolemia japan start phase ii obesity start phase category difamilast atopic dermatitis japan approve pamufetinib chronic fibrose interstitial lung disease progressive phenotype japan start phase iicontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report advance unique total healthcare company nutraceutical business mediumterm management plan call revenue furthermore work maintain highprofit structure progress major brand growth billion yen major brandspocari capable sustained business profit margin high pocari sweat sweat nature nutrition santand billion strategy include create new product concept anticipation despite effect restriction covid yen nurture brandsbodymaint equelle change business landscape expand new pandemic consumer activity sale volume pocari daiya category new region accelerate global expansion sweat beverage replenishing fluid electrolyte increase particularly overseas awarenessraise revenue mediumterm management plan rd mtm plan activity market development tailor condition billion revenue major brand nurture brand region japan addition regular activity global new product operation new business revenue nutraceutical business raise awareness heat disorder countermeasure new business profit margin activity include provide support run interhigh school championship alljapan junior high business profit margin school championship communicate maintain high importance measure prevent spread infectious disease public understanding importance build resilient business foundation replenish fluid electrolyte home increase revenue grow steadily result nd mtm plan nurture brand asiapacific sport beverage market expand review management asset major brand cagr expect outpace market underpin value chain growth forecasting cagr overseas revenue e e pocari sweat period mediumterm mediumterm management plan management plan accelerate global expansiontrend overseas revenue sport beverage market asiapacific furthermore give high level health consciousness strengthen global sale structure expand billion japan north america europe overseas million asiapacific revenue ratio cagr new region expect growth demand health pocari sweat beverage future aim grow pocari sweat overseas overseas revenue plan revenue ratio cagr billionyen brand enhance brand strength japan original marketing thoroughly communicate cagr product concept japan china indonesia south korea thailand malaysia philippine vietnam taiwan euromonitor international uk content otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report advance unique total healthcare company nature nutrition sant launch pharmavite llc californiabase corporation engage supplement nutrition sant ns found pioneer european health food specific research development nature supplement brand sell manufacturing sant mean health french company objective provide well store nutrition consumer healthy ns factory people station france sale nature japan begin brand continue grow offer belgium netherlands italy spain braziland portugal range highquality product design manufactured japanese consumer pioneer important asset ns partnership build year local farmer nature lead japanese supplement market multivitamin mineral supplement enable achieve objective source main ingredient cultivate sustainable vitamin supplement rank instore sale respective market category farming method ensure traceability today consumer government concept nature marked th anniversary continues recognize health shift human health wide concept earth health quality dedication health wellness year begin news increase value partnership stakeholder continue strengthen world report survey conduct collaboration specialist publication pharmacy time asset deliver health people name nature pharmacist recommend supplement compare precovid era percentage individual supplement day increase indicate awareness importance health rise accelerate vision nutrition sant result rise demand cagr supplement market year nutrition sant accelerate transformation base total retail sale aggregate datum report scantrack service supplement vitamin category week period end december information resources inc journeyfocuse strengthen category intage sri multivitamin vitamin market cumulative market share brand januarydecember brand like gerbl rapidly grow ecommerce news world report pharmacy time survey product category letter vitamin ae coenzyme businesswhile time simplify portfolio q omegafish oil flax seed oil herbal supplement mood health supplement diabetic multivitamin cholesterol managementnatural garlic supplement improve operating performance order fuel growth euromonitor international uk sense aim develop strong capability ecommerce core countriesfrance belgium result survey frequency netherlands italy spain portugalpropose service supplement vitamin intake yoy change nature revenue luis uribe consumer product enable president develop dc business nutrition sant oncemonth timesmonth timesweek accelerate transformation vision everyday recommend partner natural nutritional solution wellbee body mind represent important shift business strategy con tinue respect foundation base nutrition local supply chain source celebrate th anniversary nutrition sant reflect foundations precovid era pursue vision lead preventive nutritional solution precovid era dc direct consumer halfsecond half half second halffirst halfsecond half source euromonitor international ukcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report advance unique total healthcare company progress nurture brand bodymaint focus fact athlete body demand training people lactic acid bacteria b regular stress work study high risk health problem otsuka lactiplantibacillus pentosus onricb plantderive pharmaceutical research finding field intestine nutrition exercise lactic acid bacteria isolate nutrition develop bodymaint bodymaint jelly conditioning food contain fermentation type tea leaf traditionally consume proprietary lactic acid bacteria b bcaa arginine whey protein main northern thailand isolate sanae okada professor emeritus ingredient support athlete sport trainer challenge tokyo university agriculture body daily bodymaint drink conditioning beverage contain lactic acid bacteria efficacy confirm otsuka pharmaceutical b electrolyte help body hydrated convenient way consumer j gen appl microbiol regularly maintain health condition equelle equelle originate research conduct otsuka pharmaceutical saga nutraceutical equol research institute womens health research theme equelle contain equol equol ingredient produce daidzein sell japan food product support women health beauty time soybean isoflavone metabolize intestinal bacteria aspect otsuka pharmaceutical year aging bring physical mental change japan deploy dedicated staff soybean research focus propertie equol expert knowledge women health nationwide cooperation physician pharmacist saga nutraceutical research institute succeed isolate lactococcus strain lactic acid healthcare professional convey importance personal care woman bacteria produce equol publicize progress experience physical mental change activity aim maintain result variety research continue leader global research field improve health woman enhance quality life otsuka pharmaceutical provide broad range uptodate information concern womens health include women healthcare project website daiya daiya food develop manufacture sell highquality creative plantbase food product cheese alternative dressing dessert brand daiya enjoy vegetarian people food allergy healthconscious millennial generation plantbase alternative market continue grow daiya food expand sale channel product lineup mainly area cheese alternative core product mediumterm management plan plan achieve revenue cagr content otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report advance unique total healthcare company future nutraceutical business opportunity risk future initiative emerge health issue utilize expertise hone nutraceutical business involve risk stagnation pharmaceutical business otsuka group develop health awareness rise nutraceutical business global economy covid pandemic original sciencebased product maintain improve use unique expertise accumulate intensify competition soar raw material shipping people health supply product world pharmaceutical business provide solution base price shrink market japan population decline furthermore tenaciously continue activity entirely new concept address yettobeimagined need sluggish market unseasonable weather despite communicate value product create entirely health issue aim extend healthy life risk otsuka group continue search solution new product market expectancy maintenance improvement people health furthermore reinforce supply chain decentralizing manufacturing site optimize strength weaknesse logistics respond pandemicrelate change creative product marketing base scientific evidence brand development field take time consumer need current strategy target pocari sweat product longterm popularity mechanism respond unforeseen increase demand selfmedication market country overseas business incorporate solution social issue dependence manufacture site raw material supplier business engage new type marketing activity core business process concentrate specific region steady earning power major brand nurture brand improve brand w trength eakness value expand scale business accelerate global expansion new growth market opportunitie threat rise consumer awareness selfmedication prevention sluggish overall beverage market unseasonal weather daily health tandem medical cost inflation intensification competition core area entry new diversification diet competitor change consumer need pandemic pressure earning soar raw material shipping price pportunity supply chain disruption geopolitical risk hotherr efactaorstcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report advance unique total healthcare company research development otsu nutraceutical research institute otsu nutraceutical research institute rd site nutraceutical business investigate theme establish advance research nutrition exercise unique viewpoint utilize expertise hone intestinal immunity particular focus pharmaceutical business intestine play key role overall health example institute research relate saga nutraceutical research institute enhance bodys biological barrier addition develop new sciencebased product inhouse research publish datum increase secretion immunoglobulin continue undertake research replenishment fluid electrolyte nutrients iga antibody play crucial role support improve physical performance conditioning consumer mucosal immunity exploratory rd demonstrate establishment japan private research institute clinical exercise lactic acid bacteria b heightens nutrition saga nutraceutical research institute conduct rd field relate function mucosal immunity lower probability catch common cold exercise nutrition women health health issue large controlledenvironment room japan complete institute enable recreation otsu skin care research institute hypoxic environment equivalent find otsu skin care research institute perform rd cosmedic wanted improve people altitude meter health ensure skin bodys protective previously difficult recreate high covering care focus ingredient amp substance find naturally body temperaturehighhumidity low develop energy signal amp active ingredient support skin turnover temperaturelowhumidity condition encourage melanin excretion body ingredient main product facility help advance research sport innersignal series ulo contain moisturizing ingredient amp base nutrition verifying effect fluid otsukas proprietary formula product line steadily expand include moisturizer nutritional intake environment sunblock skin wash refresh sheet shampoo whitening care grow brand offer total skin care body head toe adenosine monophosphate denosine monophosphate moisturizing ingredient disodium adenosine monophosphate ot uppresse production melanin prevent skin blemish frecklescontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report advance unique total healthcare company continue activity achieve healthy lifestyle consider nutritional problem social issue otsuka group continue sponsor tokyo marathon inaugural race support work create system support people health range situation runner replenish fluid electrolyte nutrient include exercise sportwhich essential health maintain otsuka pharmaceutical official partner tokyo marathonone large urban marathon asiasince inaugural race support runner replenish activity communicate importance replenish fluid electrolyte fluid electrolyte nutrients event tokyo marathon spark run boom launch pocari sweat otsuka pharmaceutical continue communicate japan conjunction rise health awareness major factor increase importance replenish fluid electrolyte variety context follow number domestic runner thorough infection prevention measure place establishment japan sport associations study group prevention heat disorder public able run tokyo marathon time year sport activity otsuka pharmaceutical begin work association runner compete mile km dehydration loss energy muscle activity build understanding help prevent heat disorder ensue year injury issue year tokyo marathon replenish fluid electrolyte company continue provide information grow number theme include nutrient runner lose major challenge finish race safely expertise children sport labor health safety rehydration senior citizen otsuka pharmaceutical business otsuka pharmaceutical provide runner evidence pharmaceutical website include information section title protect heat base nutraceutical product relevant information continue offer support disorder section present content base japan sport association guidebook runner future race prevention heat disorder sport activity edition initiative heat disorder prevention website create collaboration weather forecaster heat disorder countermeasure suit new normal japan activity interhigh school championship raise awareness topic ensure safe operation support health competitor official addition otsuka pharmaceutical factory otsuka pharmaceutical special sponsor japan interhigh school sell os oral rehydration solution provide championship consecutive year pandemic operational support oshiete kakure championship hold thorough infection prevention measure place dassui iinkai organization raise otsuka pharmaceutical work japan interhigh school sporting association awareness way prevent treat host prefecture create system ensure thorough support prevention heat dehydration critical disorder measure include encourage use personal squeeze bottle athlete minimize interaction official prevent share drink form close contact addition support organize committee member qualified heat disorder prevention advisor company work student broadcast team draft warning announcement heat disorder way otsuka pharmaceutical support athlete event staffcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report advance unique total healthcare company consumer product otsuka food release bon curry world commercially available food plastic otsukas diversify operation include chemical business supply material pouch bag retort bag launch range product ahead field automobile electrical electronic equipment building material transportation time mannan hikari ricelike process food refined konjac flour warehousing business aim environmentally friendly logistic mainly otsuka group ingredient size series perfect people feel portion size calorie pharmaceutical food beverage electronic equipment business support count meal high zero meat meatfree product soybean development leadingedge technology otsuka chemical operation center material otsuka food aim develop kind product people happy serve friend company aim continuous technological innovation automotive electrical electronic family incorporate key ingredient flavor safety peace mind health equipment housing healthcare area provide product worldwide base original concept development capability traditional pioneering base organic inorganic highmolecular chemical technology otsuka chemical engage spirit otsuka food continue deliver original flavor new dream people table diverse material development aim offer high add value line need otsuka food smart device mobility market company go offer material propose solution industry global perspective otsuka chemical succeed development gcle proprietary pharmaceutical intermediate cephalosporin antibiotic leverage technological expertise accumulate development process company move forward research development active pharmaceutical ingredient intermediate include lactam antibiotic zero meat bon curry veggie zero meat develop solve bon curry veggie addition bon curry lineup range current social issue bring delicious flavor plantbase otsuka chemical india gcle production plant new office zhangjiagang otsuka chemical relate health food shortage ingredient use animalderived ingredient environmental impact vegetable bean produce japan bon curry otsuka warehouse provide optimal logistic solution include work external animalbase ingredient veggie unlike conventional curry use flourbased manufacturer promote joint distribution focus otsuka group pharmaceutical beverage zero meat product entirely stock instead pureed vegetable fruit gently food product daily necessity furthermore company build itbase connect logistic plantbase soy meat thicken sauce ingredient system promote paperless working environment ecofriendliness work style innovation alternative carefully select ensure product veganfriendly animalbase ingredient include otsuka food definition vegan friendly beef pork chicken product use animalbase ingredient beef pork egg milk honey seafood chicken eggs milk honey seafood product use process soybean information httpswwwotsukafoodscojpencompanybusinessveganhtml warehouse work digital device paperless office datasharing systemscontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report message director charge sustainability treatment condition undernutrition approach issue consider otsuka setting address related unmet medical need make cohesive example pharmaceutical business seek groupwide effort help eradicate tuberculosisone big infectious disease tuberculosis public health challenge realize sustainable society like covid account high number death year fact tuberculosis kill million people annually particularly prevalent develop world continue work partner world deliver drug address disparity access medicine economic factor yoshiro matsuo nutraceutical business develop innovative executive deputy president director sciencebase product leverage knowhow charge otsuka group sustainability pharmaceutical business accumulate year promotion conduct ongoing health education program aim tackle otsuka holding co ltd challenge involve access nutrition page global tuberculosis report world health organization coronavirus covid dashboard world health organization resolve social issue business clarify group commitment sustainable growth material issue select consideration people quality otsuka group company accordance social issue base characteristic strength essential sustain corporate growth corporate philosophy otsukapeople create new product otsuka group conduct broadranging business well health worldwide seek indispensable work achieve goal set nurture successive generation talent essential contributor people health worldwide wide range material issue sustainable growth company otsuka group innovative creative product include pharmaceutical know diversity people key innovation functional beverage food believe make search solution unmet need globalization development revolutionary product philosophy reality effectively achieve sustainability seek hire broad range people basic stance grow sustainably help otsuka group important mission contribute encourage effective personnel exchange group resolve social issue business accordance resolution unmet need work day help conduct training invigorate develop philosophy prevention treatment illness world workforce otsuka group global code business ethic unveil mediumterm maintain improve people health daunting code conduct business activity global market management plan announce sustainability challenge remain include threat prolong include topic human right diversity furthermore mission materiality initiative otsuka focus pandemic insufficient medical infrastructure lack effective signatory united nations global compact ofcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report message director charge sustainability stipulate principle human right labor strengthen group corporate issue amid rapid daytoday change external environment anticorruption governance environment societal demand relate sustainability women empowerment principle opportunitie participate lecture discussion underline commitment social responsibility addition otsuka group remain relevant stakeholder outside expert late trend provide release otsuka group human right policy strong governance structure necessary base realize otsuka group commit grow engage groupwide initiative ensure respect corporate philosophy otsuka holding commit sustainably accordance corporate philosophy human right page maximize corporate value sustainably medium resolve social issue business commitment quality important long term meet commitment basic policy otsuka spirit company inception quality transparent fair timely decision fulfil corporate signifie product quality quality social responsibility live expectation stage value chain rd production stakeholder engage ongoing dialogue governance distribution accountability customer quality key focus establishment otsuka sustainability management structure management continue groupwide effort holding continue work strengthen governance achieve high level quality page illustrate introduction enterprise risk management da elp ibp ely r af ior n otsuka holding otsuka group sustainability promotion leader erm july page board director otsuka holding director environmental vision net zero approval sustainability management structure proposal approval promotion otsuka group aim help resolve social issue group company otsuka group sustainability promotion committee executive charge business activity amid increase seriousness believe sustainability initiative integral sustainability climate change environmental issue business undertake promotion adopt environmental vision net zero employee end otsuka group establish call reduce total environmental impact otsuka group sustainability promotion committee examination environment procurement cr business activity zero vision identify committee form discuss area h ru igm hta sn cn ot ner tn roa promotion report promotion environmental material issue carbon neutrality circular determine direction plan group sustainability economy water neutrality set new mediumterm target effort committee member comprise manager promotion include reduce co emission compare department relate sustainabilityrelevant area group company division level raise target otsuka group supply chain environment human resource general plastic policy use recycle plantderive raw affair compliance risk management public relation activity promote conference body wgs tfs material pet bottle group work production quality include timelimite pj consumer relation achieve environmental vision net zero charge supply chain environment pursue unique initiative realize sustainable society human right relevant area committee provide pass future generation page forum share initiative progress sustainabilitycontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report health detail healthrelate initiative visit httpswwwotsukacomencsrsocietyhealthpharmaceuticalhtml pharmaceutical business challenge address unmet medical need disease worldwide contribute doctor border program secure fund basic policy bill melinda gates foundation development new tb treatment drug good health universal desire otsuka group work day help forge alliance global company place corporate presence healthcare professional world prevent treat illness help ordinary aim strength contribute public health people maintain improve health numerous challenge remain include otsuka pharmaceutical working establish protract infectious disease outbreak underdeveloped medical infrastructure system sustainable drug supply appropriate insufficient effective treatment option approach issue consider price people world access otsuka particular focus work address unmet medical need medical cost soar maintain improve health delamanid need regardless issue individual society face head socioeconomic condition income level otsuka group endeavor raise awareness healthrelate issue country live multifaceted individual team community help people stay approach see use delamanid expand healthy countriesregion end section look otsuka group initiative target unmet medical need focus effort eliminate tuberculosis world big dose treat infectious disease case ship expand access patient worldwide battle antimicrobial resistance amr alongside hivaids malaria tuberculosis tb consider world big otsuka pharmaceutical implement responsible access program prevent infectious disease deadliness comparable newcomer covid outbreak delamanidresistant tb promote proper use drug million people affect tb year million die otsuka pharmaceutical stewardship achievement include effort educate proper use increase contribute fight tb development delamanid tb drug global access delamanid conduct ongoing research development drug result year rd give world tb patient resistant tb acknowledge amr benchmark survey global pharmaceutical develop countriesregion africa asia parts world otsuka company conduct access medicine foundation fund uk pharmaceutical corporate presence work expand access tb drug dutch government diagnostic team stop tb partnership organization help develop nation purchase medicine sustainably global drug facility detail fight tuberculosis ancient disease contemporary addition work wide range stakeholder contribute people health face visit worldwide instance participate global health innovative technology ghit fund httpswwwotsukacomencsrsocietyhealthtohealthhtml publicprivate partnership headquartered japan aims tackle spread infectiouscontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report health nutraceutical business initiative yettobeimagine need provide variety information regard hold women health seminar basic policy japan furthermore launch otsuka advanced training healthy age advance medical technology improvement public health see supporter oathas program assist pharmacy pharmacist support health average lifespan increase worldwide new health challenge local community program source essential knowledge community emerge decline birthdate age population rise lifestyle health opportunity handson practical experience measure include webpage relate disease otsuka group nutraceutical business pursue range offer insight womens health include women health promotion project ko initiative aim supply world product help people maintain improve health initiative include development innovative product nenkilab content menopausal health issue pm laboratory combine scientific evidence pharmaceutical businesss accumulate offer daytoday health support woman age expertise ongoing health awareness program aim tackling challenge relate access nutrition present initiative women health offering support selfmedication trend nature support selfmedication trend global leader nutrition supplement nature develop pharmavite found pair pharmacist feel contribute total healthcare woman improve people wellness simply prescribe drug address issue otsuka group continue research topic relate women health actively engage develop range product contain nutrient essential life form close product development addition equelle equelle gele contain equol possible natural state ingredient support women health beauty time aging bring physical mental change otsuka pharmaceutical release tocoelle emerge rd focus premenstrual symptom furthermore taiho pharmaceutical launch bup lady nutritional support help family fill nutrition gap aim improve daytoday life woman urinary urgency otsuka pharmavite base handle group acquire uqora provider product womens urinary health commit development sale nature address health need broad range area contribute total healthcare woman product partner nonprofit organization feed child provide product support health year build awareness womens health partnership company donate otsuka pharmaceutical strive support approximately million children chewable woman lead active healthy life multivitamin family receive twoyear know importance building supply children vitamin reach understanding change health need family total woman life arm addition nature register dietitian individual knowledge need provide onsite nutritional education family choice right compensate nutritional deficiency women health promotion project website available japanesecontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report people detail peoplerelate initiative visit diverse human resource drive innovation httpswwwotsukacomencsrsocietypeople system generate innovation basic policy human resource development collaboration inside outside innovation drive people otsuka group attract talented group people offer opportunity skill development enable people skill establish network otsuka group view partnership collaborative effort inside outside group workplace business field actively promote communication inside opportunity help address unmet medical need patient worldwide share outside group hope generate last source innovation expertise stateoftheart technology boost drug discovery capability free fix idea improve development capability step global expansion example taiho pharmaceutical establish corporate venture capital cvc subsidiary forge network promise biotech startups human resource development academic community view generate innovation company second employee japan cvc subsidiary year gain uphold corporate culture develop global leader overseas experience professional development otsuka holding establish otsuka global academy aim ongoing identification development global human resource need sustained growth academys program develop digitallycapable human resource target otsuka group employee worldwide design run inhouse partner otsuka holding conduct variety initiative speed digital transformation outside institution area effective human resource development guide group example otsuka group ai forum share case commitment otsuka holding executive root leadership otsuka group found study group company success generally promote spread understand figure group unique approach business participant learn discuss kind artificial intelligence mainly group company president director train wide people otsuka group need generation leader skill expect spectrum technology datum science provide order help boost employee possess cultivate future leadership candidate capabilitie addition groupwide portal site launch disseminate taiho pharmaceutical partner share inhouse external information relate digitalization outside institution provide training emphasize dialogue otsuka medical device host training session university professor share uphold company longstanding corporate culture example employ artificial intelligence field medicine otsuka mindset inspire company slogan act warehouse know vital overcome challenge face logistic industry training currently target company executive seek improve literacy company intend broaden coverage go forward employee inhouse study workshop encourage employee japanese government highlight global elearning platform passport exam subsidize examination april launch global elearning gel platform employ harvard fee company commitment managementor program provide harvard business school publish corporate learning building competency include otsuka group share learn platform group employee worldwide ongoing yearround skill train far total employee group company countriesregion pass exam participate addition cultivate business literacy skill program feature message executive employee otsuka group ai forum otsuka group executive training initiative unique otsuka group employee globe include learn caf webinarscontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report people diversity inclusion health productivity management basic policy basic policy otsuka group know contribution diverse array people otsuka group believe maintain workplace enable conducive innovation globalization development innovative employee work good health spirit vital making share corporate product embrace promote diversity group company drive philosophy reality think declaration health innovate committed ensure workplace welcome people major otsuka group company promotion system promotion system diversity inclusion promotion team group company lead effort otsuka holding executive deputy president director charge health productivity great diversity inclusion individual company coordinate group initiative management supervision otsuka pharmaceutical health insurance association initiative include plan groupwide system conduct seminar hold regular meeting group companys health productivity promotion manager specialist staff share company effective example diversity inclusion industrial physicians nurse work collaboratively entire organization help maintain enhance health employee family result initiative otsuka collaborative group activity group company select ministry economy trade industry certify health productivity management outstanding organization recognition program japan introduce family smile support system encourage employee work home beforeafter parental leave take childcare nursing care raise healthawareness employee business activity obligation system lead improvement work efficiency productivity worklife balance introduce work interval system mandate minimum rest period hold seminar variety topic aim deepen employee understand shift worker hold regular groupwide diversity seminar total people group company activity encourage health health attend seminar hold fiscal fiscal know family think total employee attend online seminar women employee aware issuestheir boss broaden awareness health cancer seminar hold headache presenteeism alcohol establish ikuboss manager supportive worklife balance declaration consumption furthermore employee otsuka pharmaceutical factory produce series lead increase female manager ratio number employee take online health support video benefit colleague parental leave refer financial nonfinancial highlight highlight boost mental physical health virtual run highlight conjunction world mental health day pocari swet run charity event take place otsuka america pharmaceutical recipient hbas ace award october november collaboration silver ribbona mental health otsuka pharmaceutical establish otsukas network awareness npo base singapore event virtual running race utilize smartphone app otsuka woman drive effort participant choose distance donate npo base far manage run diversity equity inclusion key part global business runner include otsuka group employee japan indonesia lace strategy membership employee run shoe take event connect woman opportunity consider succeed race participant join online grow workplace member high seminar hear psychiatrist athlete talk promotion rate recognition initiative otsuka america pharmaceutical mental health focus mental welling receive advancement commitment engagement ace award exercise hydration event kind healthcare businesswomens association hba highlight otsuka work closely support consumer mental physical health award honor company commit ensure gender diversity leadership opportunitie woman organizational dna utilize synergy core businessescontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report quality detail quality dorelate initiative visit httpswwwotsukacomencsrsocietyquality field fieldspecific quality challenge basic policy help build sustainable society otsuka group guide endure philosophy ethical consideration accordance law guideline customer quality pursue quality stage value chain research comply relevant law guideline strive uphold promote initiative take account environment society human right development bioethic scientifically valid methodology viewpoint preservation environment safety management sustainable procurement cooperation supplier share otsuka group procurement policy otsuka group sustainable procurement procurement guideline supplier carry robust diligence select new supplier work supplier promote sustainable procurement regard legal compliance consideration environment human right issue research development groupwide teamwork ensure stable supply highquality product comply relevant law regulation administrative instruction industrial standard work obtain international customer production certification quality food safety management standard addition service procurement quality control observe law regulation country business patient base gxp perform quality control quality assurance utilize global safety surveillance system implement postmarkete safety measure include customer safety collection monitoring safety information concern adverse event gxp good x practice general term good practice standard ministerial ordinance regulation guideline establish government public institution ensure safety reliability building logistics foundation ultimate mission production quality ensure supply stability msa al ks e tin nd g co cn ut sr ol man ed r sp aa ft eie tynt logistics rigorously control maintain product quality pharmaceutical food product beverage distribution furthermore incorporate transportation business continuity planning include registration vehicle authorize access restrict area emergency logistics appropriate promotion enhance information access establish code practice build international federation pharmaceutical manufacturers associations code practice japan pharmaceutical manufacturers association promotion code sale prescription drug addition comply code otsuka group quality vital factory packaging manufacture marketing company observe industry rule guideline provision market put consumer position sale information prescription drug conduct sale marketing activity responsibly high level ethic establish otsuka begin manufacture sale injection drug otsuka founder expert panel comprise member draw multiple department perform review marketing plan sale promotion material busaburo otsuka write guide principle clarify employee ensure proper manufacturing transportation sale sincere response inquiry reflection company activity today principle display otsuka group manufacture site establish dedicated customer contact point staff specially customer train personnel field inquiry tailor characteristic facility convey philosophy customer quality service particular drug quasidrug food product respective product employee otsuka group remain true philosophy past opinion suggestion product service proactively share group purpose product development improvement responsibility healthrelated company think customer quality firstcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report quality procurement sustainable procurement cooperation supplier sustainable procurement initiative basic policy embed sustainable procurement train otsuka group signatory united nations global compact ungc consider compact position human right labor environment provide sustainable procurementrelate training take consideration human right anticorruption universal value procurement guide otsuka environment issue order embe otsuka group procurement group procurement policy set direction consistently uphold policy otsuka group sustainable procurement guideline group ungcs value maintain sustainable procurement practice accordance specific task force work improve skill procurement staff provide corporate philosophy otsukapeople create new product well health opportunity learn sustainable procurement issue topic worldwide improve corporate value make contribution society briefing sustainable procurement practice target conduct briefing supplier promotion system progress conduct briefing supplier otsuka sustainable procurement task force supervise otsuka holding director hold briefing supplier sustainable procurement practice attendee learn comprise otsuka holding group company form task force otsuka group procurement policy otsuka group sustainable procurement guideline meet month share view challenge exchange information report expectation compliance event opportunitie party stay company progress addition formulate otsuka group sustainable procurement uptodate human right environmental issue hear example group guideline september concrete guideline supplier follow initiative action supplier agree uphold policy sign pledge affirm start otsuka group begin focus new areastability supply intention cooperate achieve sustainable procurement business partner address natural disaster geopolitical risksin addition exist area attention human right labor environment anticorruption selfassessment questionnaire saq sustainable procurement target conduct saqs supplier otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical otsuka chemical otsuka food otsuka packaging industry otsuka techno en otsuka pharmaceutical progress conduct saqs domestic overseas supplier supplier sign pledge conduct selfassessment consist common saq publish global compact network japan human rights saq environmental saq develop take account characteristic otsuka group business activity base result conduct interview supplier seven company interview fiscal interview conduct remotely pandemic measure share example sustainable procurement practice opportunity learn successful case study cooperate address specific concern ensure supplier tangible progress sustainable procurement group meeting sustainable procurement attendee include director executive officer procurement staff otsuka holding otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical otsuka chemical otsuka foodscontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report quality production quality control patientcustomer safety groupwide cooperation ensure stable supply highquality product department japan world ideal opportunity share learn basic policy manufacturing error case study company otsuka group believe provide stable supply highquality product promotion system quality control patientcustomer safety contribution sustainable society accordingly seek effective use characteristic business include pharmaceutical food chemical product otsuka group design system quality control patientcustomer safety accordance cosmedic quest level quality justifie customer faith end characteristic business pharmaceutical food chemical product believe vital pursue talent development departmental border maintain cosmedic comply act secure quality efficacy safety product reliable quality assurance system span relevant company advantage include pharmaceutical medical device observe law regulation country enable stay abreast change operating environment minimize quality operate perform quality control base good quality practice good vigilance risk undertake dynamic initiative contribute supply chain stability practice manufacture sale implement postmarkete safety measure otsuka group system production quality safety management compliant relevant law regulation administrative instruction industry standard submit necessary report regulatory authority update maintain require include prescribed act secure quality efficacy safety product documentation addition regard manufacture sale pharmaceutical otsuka include pharmaceutical medical device food sanitation act furthermore group company information exchange general marketing compliance officer aim obtain appropriate standard certification iso quality iso quality assurance manager safety control manager establish fssc food safety foster quality culture go pharmacovigilance system facilitate constant collection assessment product safety minimum obligation require law information group worldwide enable provide information swiftly medical institution otsuka pharmaceutical overseas group company establish global product promotion system production quality policy implement measure ensure reliability qualityrelate datum publish manual outline common procedure strive improve quality system instance otsuka group aim maintain stable supply highquality product end hold annual management reviewsglobally otsuka international asia arab division production department practice stringent production management facilitate trace japanin order promote compliance good clinical practice good vigilance product entire supply chain procurement raw material practice good manufacturing practice development commercial sale production distribution sale product quality department pharmaceutical business nutraceutical business share information hold discussion implement technical improvement group jointly hold annual global product quality meeting meeting hold online attend wide manager staff otsuka group factory world come approximately executive quality supervisor pharmaceutical nutraceutical supervision group company executive global production meeting hold countriesregion include japan attendee share information change social year lead new activity leverage strength otsuka group conduct landscape quality improvement initiative addition quality performance award broadrange business include promotion crosscompany technical exchange establish recognize quality control initiative effort train people quality term daytoday production know importance reflect learn control raise awareness past performance end hold manufacturing error workshop twice year meeting bring representative group company production policy establish pharmaceutical business nutraceutical business commitment nc global quality policy year technical exchange global otsuka pharmaceutical quality assurance office quality production meeting headquarters inaugurate global product quality team member global production meeting return fiscal gap otsuka group company world involve year covid pandemic meeting nutraceutical business otsuka pharmaceutical approach quality hold online theme new form production root remain faithful founder busaburo otsukas word attend employee executive country quality vital factory packaging manufacture ken konagai region participant present case study include report market put consumer position ryo harima remote support launch new overseas plant use director key message nc global quality policy customer v di ec pe u p tr ye gsi ed ne en rt al manager big datum analysis system production exchange view qf uf aic lie yo af n ssu ut rr aa nc ce eu tical delight quality express founder sentiment production headquarters join ceremony production award quality headquarters word declare common global commitment otsuka pharmaceutical recognize outstanding production achievement otsuka pharmaceuticalcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report quality customer service sincere response inquiry reflection company activity reflect stakeholder view company activity basic policy recognize respect consumer right important human right issue customerface department otsuka group company receive broad variety feedback declaration consumeroriente commitment october establish patient healthcare professional consumer sure feedback share basic policy commitment social responsibility corporation appropriately relevant department strive share feedback fulfill pursuing consumeroriente management make appropriate decision base dialogue stakeholder value chain right executive department properly reflect company activity value chain communication stakeholder promotion system patient crossgroup otsuka sustainable procurement otsuka group company establish dedicated contact center field inquirie consumer procurement task force communicate closely supplier promote sustainable procurement patient healthcare professional general consumer center staff train personnel provide information appropriate inquiry report relevant department otsuka pharmaceuticals tokushima itano factory management team company view suggestion product dre es ea lorc ph en nd production tsd u h kau foa r se ts oo ku urc se h d av e fl ao cp tom n ht ln ds oit nu lit ne e inform future improvement factory tour community outreach customer procurement quality addition collect feedback groupwide customer service liaison meeting service control consumerrelation office otsuka patient pharmaceutical collect analyze consumer hold groupwide customer service liaison meeting year customer comment social medium incorporate supervision otsuka holding director meeting attend representative company safety comment product improvement pharmaceutical business nutraceutical business consumer production otsuka warehouse handle otsuka product business daily necessity ecommerce category msa al ks e tn ind g q au na dlit py c tio en not tr ol group logistic operation hold meeting customer safety transport partner necessary share policy relevant department company report logistic initiative engage mutual customer service activity initiative great consumer employee exchange aim promote digital logistic transformation operational improvement orientation foster consumeroriente corporate culture th meeting hold focused evolve consumer trend amid swift dissemination information online sale tool enable provide information social change ongoing covid pandemic good practice marketing pharmaceutical nutritional product product improvement inform customer feedback switch labelless bottle compromise strict covid countermeasure reflect customer feedback groupwide initiative leverage customer feedback high hope deep permeation consumer otsuka pharmaceutical quality assurance office orient management quality headquarters consumerrelation office hold deep respect people otsuka group annual listen customer feedback meeting year meeting work hard create sustainable society consumer hold online december connect consumerrelation inspire ideal ethical consumption found key office office tokushima osaka tokyo production plant concept environment worker right happiness attend representative sale production community age long count future toshifumi fujishita quality procurement head office department prof izumi kado direct extension past convince otsuka director member otsuka holding participant hear customer feedback department business group consumeroriente management style imbue spirit consumerrelation office product example feedback communication altruism define diverse indepth ethical communication otsuka pharmaceutical shikoku university incorporate product improvement junior college stakeholder come share widely worldcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report environment detail environmentrelate initiative visit httpswwwotsukacomencsrenvironment environmental vision net zero otsuka group establish environmental vision net zero aim reduce total environmental impact business activity zero work mediumterm target advance initiative achieve sustainability mission overall goal carbon contribute neutrality healthy sustainable target society environmental vision reduce simultaneously net zero co emission achieve growth compare water circular neutrality economy target target target ongoing initiative reduce environmental impact expand plant water reduce content management program simple recycle location globally incineration plantbase develop water use strategy landfill disposal material business location compare pet bottle waterstresse area materiality material issue social issue goal activity carbon neutrality global warming target reduce co emission compare reduce co emission value chain target r educe simple incineration landfill reduce environmental impact improve resource circular disposal compare efficiency environmental load increase economy target content recycle plantbase material promote business activity aim sustainability pet bottle society earth target e xpand plant water management program water reduce freshwater availability location globally understand water resource risk neutrality water resource risk target evelop water use strategy business location management effective use water resource waterstresse area sustainable energy use sustainable use raw material sustainable use water resourcescontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report environment otsuka group environmental management system basic policy aiming create healthy future total healthcare company otsuka group otsuka group sustainability promotion committee establish environmental vision net zero aim reduce total environmental impact business activity zero base vision determine material issue environmental sharing promotion initiative carbon neutrality circular economy water neutrality global otsuka holding action aim decarbonize society gather speed establish new set executive deputy president environmental committee chairperson mediumterm target aim proactive initiative director otsuka holding make decision promote activity improve employee understand recognition environmental strategy environmental issue environmentrelate training generate synergy committee director executive officer approval goal otsuka group company act unified standpoint activity plan member otsuka group company proposal report approval carbon neutrality otsuka group global person charge environmental environmental council chief officer management otsuka holding global warming result change climate major impact formulation goal world bioresource water resource environmental problem activity plan person person charge environmental reporting result apparent global scale group operate globally recognize climate charge management otsuka group company activity change present major risk time offer new business opportunity aim contribute decarbonize sustainable society work reduce greenhouse gas ghg emission value chain line international strategy target indicator adopt paris agreement otsuka group conduct climate change scenario analysis assess resilience strategy specifically reference ieas world energy outlook material assess business disclosure accord tcfd recommendation risk opportunity c scenario c scenario october otsuka holding announce support recommendation change global mean surface task force climaterelate financial disclosure tcfd accordingly move temperature c scenario forward disclosure information climaterelate scenario development dependent fossil risk opportunitie governance strategy risk fuel climate change measure introduce management metric target accord r wi ase rm n g coc un e r mc e aif un ro e sa ad reit ka enl global r ni es gin ag ti vt ee imp pe ara ct tu ore ns cc ra ou ps se aa nn n locr se os fe bin io n da ivt eu rr sa itl yd isaster framework recommend tcfd c scenario scenario development sustainable governance climate change measure proactively implement temperature rise c measure otsuka holdings environmental committee comprise executive deputy president director achieve decarbonize society enhance include otsuka holding group company director executive officer committee responsible making r wi ase rm n g c oc u n te rmc e aif ud rr ea ss aic r eg l ab ka enl eh xe p nt sr io od nu oc ft hn e ref nc eo w ae bm lei es nio en rs g yre mgu al ra kt eio tns year decision key challenge relate climate change furthermore resolution matter relate groupwide direction share company follow approval board director base ministry environment japanese translation summary policymaker working group ii report fifth assessment report publish ipcc matter communicate company form otsuka group policy incorporate main scenario reference specific action plan board director approve environmental vision net zero iea world energy outlook sustainable development scenario state policy scenario aim reduce total environmental impact business activity zero ipcc rcp rcp oecdfao agricultural outlook content otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrated report environment scenario analysis financial impact response associate risk management climaterelate risk opportunitie otsuka group examine assess climaterelate risk potential impact business financial affair strategy otsuka holdings environmental committee consider related risk financial impact category content responseresilience committee member charge environmental management report matter c c deem significant risk assessment process board director resolution matter policy ncrease cost tighten approve board director communicate company form otsuka group regulation regulation carbon price large large introduction internal carbon pricing policy group work minimize climaterelate risk introduction cofree electricity transition market steep rise renewable energy price large large introduction solar power generation system include mega risk steep rise energy price large large solar power system metric target improve energy efficiency energy save fuel reputation risk investmentrelate conversion reputation risk associate inadequate response large medium investment environmental facility japan overseas otsuka group establish environmental vision net zero aim reduce total climate change water resource risk environmental impact business activity zero addition revise co emission r isk damage production decentralize production major product reduction target upward reduction reduction compare facility intensification extreme formulation disclosure share procurement policy weather cost increase prepare guideline supplier join international initiative continue promote activity aim acute extreme weather event medium large strengthen communication supply chain expand r isk raw material procurement number supplier subject supply chain decarbonization look ahead maximize group synergy proactively engage effort achieve physical disruption supply chain stable questionnaire improve enhance content carbon neutrality procurement questionnaire hold discussion risk ncrease energy cost associate large large systematic renewal facility temperature rise chronic e ffect climate change drug collection information impact drug discovery target target reduce co emission compare discovery crop natural medium medium crop natural product risk assessment product examination countermeasure fiscal ic tr e dm ui cs ts ii oo nn fr e rd eu nc et wio bs l eth er eu rg gh co emission r efe fs ico ieu nrc ce r ine trd ou dc uti co tn io nf oo fp ee nra ert gin yg e c fo fis ct ies nth rough large medium c will al tl ee rc ti ro en mf ein nf tr em ht nio lo gn tn aw dte oc eh n olo g reie qs u irs eu c sh te ae nm db rane nc ea ur tb rao ln result tco tco equipment examination introduction technology timely manner introduction internal carbon pricing energy r toe pu roc ati co tn iv eo f ne tn roer dg uy c p tir oo nc u fe rm ene en wt ari bsk le ue large small collection information nextgeneration energy source target target reduce simple incineration landfill disposal compare source energy hydrogen ammonia examination introduction target content recycle plantbase material pet bottle source timely manner formulation otsuka group plastic policy aim total waste volume simple incineration increase revenue increase reduce reliance fossil fuelderived material circular fiscal landfill disposal volume oppor product demand product mitigate examination introduction recycle pet resin plantbase economy result address climate change eg product large large biopet resin pet bottle beverage container tunitie service prevent heat stroke spread example expand sale product prevent heat stroke infectious disease expand sale product low environmental impact lifecycle target target expand plant water management program location globally target develop water use strategy business location waterstresse area increase revenue expansion development product mitigate address climate change market new market category product medium medium address climate change eg plantbase product water usage water intensity unit sale fiscal strengthen business continuity et nr ee rn gg yt h rn oi un gg h n p tero rnm ao l ci ao rn b n e pn icr ig ny g save renewable new uta rt ae lr result million million resilience planning measure disaster medium large supply chain disruption b au ns ti se es mco icn min eu ait sy u p rela n nm de mas eu sus ra et aga iu nf sa tc ft lu oin dg gi tes calculate base performance manufacturing site consolidate otsuka group assessment businessfinancial impact large billion yen equivalent operating income assume minimum operating income billion yen medium negligible billion yen small negligiblecontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report environment join initiative introduce co free electricity indonesian group company april otsuka group join international initiative ask company commit renewable energy business activity overseas business high generator co emission japan world transition decarbonize society environmental vision net zero indonesia engage pharmaceutical nutraceutical chemical aim reduce total environmental impact business activity business indonesia introduce cofree electricity geothermal power zero continue proactively implement measure reduce co emission forecast reduce annual co emission move forward continue increase use renewable energy maximize energy efficiency japan world use group synergy contribute decarbonize sustainable society pt otsuka indonesia pt amerta indah otsuka pt widatra bhakti pt lautan otsuka chemical increase utilization renewable energy maximize energy efficiency otsuka group set target reduce co emission compare achieve target increase renewable energy usage introduction cofree electricity solar power generation equipment maximize energy efficiency adoption cogeneration system introduce cofree electricity manufacturing site otsuka group company result reduce annual emission approximately sukabumi factory pt amerta indah otsuka tco furthermore tokushima prefecture home otsuka group production facility begin upgrade cogeneration facility otsuka build new integrate energy service structure chemical tokushima factory enable supply electricity steam neighboring otsuka group manufacture site improve energy efficiency new effort achieve environmental vision net zero reduce total cogeneration system schedule begin operation expect cut annual environmental impact business activity zero otsuka group establish emission approximately tco addition introduce new co new integrate energy service structure retail electricity provider model generation system change boiler fuel otsuka pharmaceutical factory naruto able procure renewable energy power producer factory result annual reduction approximately tco source efficiently supply electricity generate otsuka group group engine turbine fuel cell cogeneration system generate electricity natural gas lpg fuel business site source time system collect waste heat achieve efficient use heat electricity otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical otsuka chemical otsuka food compare content otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report environment circular economy water neutrality line global trend able create sustainable society achieve water resource unevenly distribute country region face sustainable corporate growth shift sustainable business model different challenge work stakeholder conduct ongoing water achieve growth impact environment continue offer conservation initiative intake discharge include cultivation water resource product contribute health people worldwide set goal conscientious use clean return aim sustainable water use reduce simple incineration landfill disposal waste compare use revise target include develop implement water use strategy business recycle plantbase material pet bottle otsuka group site waterstresse area expand plant water management program plastic policy continue increase resource efficiency value chain location globally build harmonious sustainable relationship bioresource resource source work group company use world resource institutes wri aqueduct goal revise previous goal content recycle plantbase material pet bottle water risk atla extensive waterrelate datum assess water risk manufacture site scope consolidation base assessment draw model case water management water target tailor country region container package pet examine evaluate result launch similar initiative site worldwide sustainable society bottle base otsuka group plastic policy quickly move forward measure reduce environmental processing collection aqueduct water risk atlas breakdown region water consumption pet resin otsuka group impact cause plastic container package bottletobottle contribute sustainable close loop recycling plastic resource washing crush europe launch pet bottle recycled material launch pet bottle recycled pet resin crystal geyser japan north april recycle pet america water stress east high asia bottle pocari sweat march high south asia move forward n rth africa e r te high technological development sou sh ie aast mo eu rt ih l lo ow w oderate gradually extend use recycle use dry low water ml ml ml ml ml data pet bottle product source wri aqueduct water risk atlas crystal geyser pocari sweatcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report message outside director text message visit httpswwwotsukacomenirmanagementmessageoutsidemessagehtml unique corporate culture found important examine truly global evolve corporate governance continue reap benefit maintain found family spirit otsukas development diversity unique approach biological evolution continuous process individual specie group successfully adapt yukio matsutani surround environment pass gene environment change easy predict outside director otsuka holdings co ltd species able adapt give change sense believe rich diversity otsuka group business enable continue evolve time hand rich diversity come appointment present day governance structure maintain found certain inefficiency aim global governance familys spirit otsukas unique approach deal inefficiency group otsuka group achieve growth list important issue global corporate determine manage group charismatic management founding governance risk management global governance leave local operating company deal family list company shift extremely complex country challenge way market differ country stage owneroperate company leadership course issue deal development group business business choose shareholder structural transition feel group steadily build organizational purpose differ overmanage business lead disruption area include corporate structure address lead inefficiency clarify responsibility time governance otsukas case relatively criteria investment liquidation decision smooth group success respect doubt evaluate success failure particular business partly ceo tatsuo higuchi longtime veteran progress challenge global governance important overmanagement costly give otsuka group understanding difficulty determine found family spirit expertise global give diversity otsuka group shareholder eliminate organizational perspective management group expand scale customer client stakeholder essential necessary create platform decisionmake base business growth truly global company carefully discuss good overall structure evidence datum address evolve management corporate global governance group enjoy benefit ofcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report message outside director numerous personnel system wage structure make difficult implement share service company ensure effective personnel utilization maximize value education increase groupwide value generate sustainable role responsibility group company clarify important organizational growth group perspective create global personnel system strategy link level contribution company group addition give consideration ideal remuneration system ko sekiguchi cover variety business type enhance group governance outside director otsuka holdings co ltd responsibility contribute fulfill important role group live era continuously create progress enhance group governance capital cost executive director cfo yuko makino lead develop novel innovative pharmaceutical difficult effort addition introduction expansion important business operating addition ensure smooth development share service move forward consider service company responsibly engage initiative operating company business otsuka holding extremely important factor enhance group awareness contribute group manage focus maximize value ensure governance group company differ scale structure role fulfill nutraceutical business sustainable growth group industry stage development group stand unique unrivaled position march managing director shuichi takagi considerable effort incorporate service great potential innovation appoint cso strengthen corporate strategy nonetheless believe progress steady company world cover function otsuka holding believe significant prevention recovery step enhance group governance step believe need improve groupwide deepen discussion goal importance global personnel strategy communication strategic consideration investment operate company align otsuka holding decision strategy entrust investment company clear role addition introduction operation operating company extensive experience perform group keep mind groupwide share service global personnel function fulfill expertise competitive advantage specific field synergy group vision year key role group governance currently operate lead great value important finance mediumterm company responsible formulation approach give group aim capital cost management plan group state intention conduct implementation personnel system account management business management corporatewide awareness strategy global perspective havingcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report message outside director human resource development rotation allocation function otsuka holding develop increase create robust mechanism number management personnel group company anticipation globalization development growth nutraceutical consumer product business compare management foundation yoshihisa aoki pharmaceutical business nutraceutical business outside director consumer product business otsuka holdings co ltd development stage say unique development business lead steady growth foundation consumer product market system value undergo major change environmental issue need address infectious disease challenge global governance rebuild mechanism otsuka holding need factor otsuka group utilize bold investment clarify scope scale responsibility take change opportunity employ management otsuka group base group company ensure group direction unique approach believe scale business competition operating company approach profitability affect otsuka holding need increase significantly enable grow unique total healthcare company strengthen management capability world complex number operate company respect independence otsuka group company reach mark time carefully balance responsibility found spirit believe time reexamine group direction control hold company responsibility review mechanism keep track list entrust operate company otsuka group easy manage company maintain faith company otsuka holding responsibility contribute management mechanism place believe found spirit otsuka group found stakeholder boost management robust mechanism require group spirit continues pass group efficiency enhance profitability consequently continues develop globalization corporate philosophy hope group group establish new direction rebuild number group company continue increase use philosophy provide solution mechanism maintain found spirit significant focus personnel development benefit people society appointment managing director shuichi takagi cso group stage preparation march reflect group intention prepare expansion strengtheningcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report message outside director success visible inspire successful collaboration operating company project consider management topic investment rd expansion sale channel otsuka group policy business largerscale investment single entity strategy enhance group adopt large risk appetite investment promise domain external collaboration value otsuka group recognition gain group comprehensive strength significant mayo mita possible lone operate company outside director hand group correct otsuka holdings co ltd choices social demand change time important create new mechanism allow group new challenge turn lead virtuous cycle different business natural kpi differwhat important otsuka group value organization corporate value globalization innovation synergy set kpi management undertaken board director constantly consider sense ownership responsibility embed otsuka group grow huge organization management policy business strategy well improve concept cost capital roic diverse corporate history operating company value otsuka group operate company group difficult task board director corporate governance convert indicator numerical target way committee continue deliberate increase decisionmake transparency business group true ability maximize underlie value innovation efficiency creativity execution governance business group use strong management foundation detail investment priority maximize group synergy value doubt increase otsuka group structure enable create list company otsuka holding date creativity operate company inspire facilitate relationship group unlike welcome shareholder new category stakeholder mutual improvement enable group generate external collaboration pioneer example include shareholder purchase share otsuka holding numerous innovation current speed scale collaboration taiho pharmaceutical look forward sustainable growth change digitalization borderless information share otsuka pharmaceutical sale anticancer agent group communicate group commitment external trend unprecedented amid environment partnership otsuka medical growth category stakeholder doubt lead great corporation improve device otsuka pharmaceutical believe make improved relationship trustcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report message outside director maintain well health society important directly address need patient consumer community representative example governance pharmaceuticals abilify maintena drug develop schizophrenia patient offer convenient otsuka move prescription format solution issue face right direction society life pocari sweat example sale begin bottle time direct contact consumer aspire great height raise awareness product advantage build popular brand year later otsuka develop pocari sweat ice slurry support construction tatsuaki kitachi worker work extremely hot condition promote site product outside director create product development otsuka holdings co ltd marketing activity efficiency mind key mission enhance financial efficiency governance express strive otsuka today otsuka group comprise company include corporate philosophy affiliate company conduct independent management independent company otsuka group communication reference operate company engage multiple business otsuka group corporate philosophy otsuka uniqueness approach suit longterm business otsukapeople create new product well health connotation specialness exclusivity management include personnel development worldwideis prime expression group word express group willing use strong important reinforce method tool require approach governance word well leadership challenge manage financial accounting managerial accounting health worldwide group desire ensure research development require longterm different perspective current environment well health governance emphasize commitment process management supportive significant movement macroeconomic constructive approach governance word colleague partner large investment level essential find beneficial mean look eliminate revise create guarantee success rd small implement financial management capital efficiency new product expression group investment lead major fascinating result group company otsuka group willingness new challenge reach great outcome project difficult foresee incorporate approach enhance financial efficiency height role outside director ensure important rd leader commit support centralized capital management foreign exchange risk governance otsuka group team necessary create network exchange management improve financial efficiency key group move right direction aspire great information forward gradually revise meet expectation shareholder investor height direction project necessary believe otsuka present significant challenge group apply capability great effect group tacklecontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report message cso seek reinforce strategic proactive approach cooperation increase opportunity discussion implement robust group asset strength strategie precautionary approach cooperation enhance monitoring operating governance management company quickly find solution emerge business ensure continue contribute challenge hold discussion way create robust organization include overall life customer direction group significance relevance business diversity value creation shuichi takagi total healthcare company otsuka group success manage director cso chief strategy officer ground diversity industry otsuka holdings co ltd business human resource expertise bring furthermore operate company different stage growth group big strength ability integrate different idea value combine creativity operating society continues diverse perspective enable respond company group governance operating environment rapidly change change generate entirely new value go measure continue meet expectation business management hold company otsuka group currently comprise company stakeholder provide social value sense value creativity business develop opportunity date operating company group imperative integrate creativity management small project grow major success offer accumulate creativity strength offer unique capability operate companieswhich support creation new value group synergy business undertake independent management responsible carefully examine social need move forward look promote interaction inspire mutual improvement generate broad identify value createwith group employee create new environment range innovation process shift governance key enhance effectiveness play active role organizational personnel hold company structure introduce share group management systematic overarching development program leverage employee diversity service improve corporate function seek perspective particular rapid recent change otsuka group aim continue contribute accelerate group synergy innovation end social environment need rebuild supply chain network people live total healthcare company building build mechanism optimize asset use promote certain business difficult anticipate strong relationship trust enhance cooperation collaboration example informationshare future bring group look grow scale group strive ensure robust platform operate company share value chain promote global development year group governance managementcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report governance details governancerelate initiative visit httpswwwotsukacomencsrgovernance corporate governance initiative strengthen corporate governance remuneration institutional design corporate governance measure director basic policy establishment otsuka holding otsuka holdings co ltd company commit promote sustainable term director set year appointment outside audit increase corporate value medium long term realize supervisory board member begin corporate philosophy otsukapeople create new product well health worldwide meet commitment adopt basic policy make transparent stock publicly list december stock option performance link remuneration introduce fair timely decision fulfil corporate social responsibility live expectation stakeholder include customer business partner mediumterm management plan announce employee local community shareholder ongoing dialogue appointment outside director begin second mediumterm management plan announce otsuka group global code business ethic establish corporate governance guideline otsuka group global anticorruption policy establish httpswwwotsukacomencsrgovernancepdfgovernanceguidelinepdf corporate governance guideline establish corporate governance report april internal whistleblowing system otsuka holding major group company establish report httpswwwotsukacomjpcsrgovernancepdfgovernancereportpdf available japanese independent body outside company system grant stock effectiveness board director evaluate option conditional progress medium corporate governance organizational structure term management plan introduce shareholder meet corporate governance committee corporate governance guideline revise electsdismisse electsdismisse electsdismisse establish start evaluate effectiveness board director base questionnaire complete corporate consult board director ap cce ora ut nio tin na gl aa uu dd ii tt ss audit supervisory board director audit supervisory board member governance recommend director outside director audit supervisory board start hold reporting meeting outside committee appointsdismisse mem oub te sr e e mw bh eo rm director outside audit supervisory board member improve understand president group management business representative director ceo cooperate cooperate accounting audit female director appoint corporate governance guideline revise instruct report instruct report account auditor internal control internal audit restrict stockbase mediumterm management plan announce department department compensation plan introduce cooperate approval meeting prior otsuka group global policy conflict interest material matter group board consultation establish management corporate ex post guidance auditor facto report accounting auditor change corporate governance guideline revise subsidiary shareholder meeting board director audit supervisory board member etc otsuka group global antifraud policy formulate ratio independent outside director otsuka group global speakup policy formulate increase thirdcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report governance board director director skill matrix line board director regulation board director convene regularly technology strategic legal healthcare major global planning finance compliance company rd administration qualification month hold extraordinary meeting necessary important business business production marketing accounting risk analysis public health etc sale management decision supervise execution operation ichiro otsuka term director otsuka holding set year clarify executive responsibility fiscal year furthermore company work ensure overall tatsuo higuchi diversity director appoint people insight expertise experience need yoshiro matsuo realize maintain appropriate effective corporate governance internal yuko makino director comprehensively evaluate experience expertise insight attribute shuichi takagi candidate ensure quality need implement group masayuki kobayashi corporate philosophy code business ethic management strategy outside director company look individual wealth knowledge extensive noriko tojo experience field company require candidate ability makoto inoue adequately exercise management oversight function fair objective monitoring yukio matsutani md supervision auditing management neutral objective viewpoint ko sekiguchi meeting hold fiscal average attendance yoshihisa aoki mayo mita ratio independent director ratio female director tatsuaki kitachi cpa outside director female director inside director male director director selection criteriaindependence standard outside director httpswwwotsukacomencsrgovernancegovernancesystemhtml reason nominating director refer notice call th annual shareholder meet httpswwwotsukacomenirstockpdfmeetingpdf content otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report governance evaluation effectiveness board director major matter deliberate board director category major report discussion fiscal january february company conduct questionnaire survey director audit supervisory board member result survey review monitor progress consolidated result plan business performance discussion current condition issue performance company attorney consider evaluated board director meet plan operate company business segment march monitor progress mediumterm management plan questionnaire item follow identification issue improve effectiveness board director composition board director approval officer election remuneration director understand knowledge business field specific management corporate governance monitor subsidiary activity strategy plan confirmation progress measure reinforce group governance review crossshareholding cooperation outside director cooperation audit supervisory board formulation group energy strategy approval support recommendation task force climate operation board director meeting related financial disclosure tcfd governancerelated matter confirmation status execution program cultivate management sustainability personnel function board director determine direction management strategy formulation environment vision net zero approval revise ii monitoring business respect execution management strategy material issue approval join international initiative iii understand perspective major investor stakeholder iv risk management discussion license agreement joint development commercialization otsuka pharmaceutical sumitomo dainippon pharma sumitomo v cooperation information share operate company partnership pharma subsidiary sunovion pharmaceutical support system outside director discussion pharmavite acquisition uqora operation corporate governance committee meeting frequency agenda etc approval internal control report update implementation global training overall function board director perspective effectiveness program confirmation conflict interest approval activity report activity plan annual report internal whistleblowing system whistleblowe system risk management improvement status number report overview approval action plan summary evaluation fiscal formulation new global policy otsuka group human right policy otsuka group global antifraud policy otsuka group global speakup policy overall opinion improvement previous year report erm monitoring activity board director function appropriately standpoint effectiveness report progress initiative reinforce overseas crisis management nonetheless result confirm need ongoing effort improvement area role company hold company approach fully formulation funding policy coordinating share information subsidiary stance company financial strategy discussion new capital investment respect investor stakeholder formulation dividend policy reinforcement cyber security measure report otsuka group activity etccontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report governance corporate governance committee ratio independent major matter deliberation outside director otsuka holding establish corporate governance committee february outside director nomination director audit supervisory board member advisory body board director committee discuss matter relate inside director nomination succession plan enhancement corporate governance structure include nomination director audit supervisory board member succession plan remuneration remuneration remuneration system level director audit supervisory board member system remuneration level director audit supervisory board member report result deliberation board director committee seven corporate improvement group governance global members president director charge administration outside director governance matter g po rov mer ta ion nce e tcr ganizational structure innovation publication report president serve chair committee effectiveness corporate governance committee audit supervisory board initial role corporate governance committee nomination remuneration committee committee continues effectively carry role allocate ratio outside audit supervisory board member attend express time discussion corporate governance overall great freedom board audit supervisory director feel committee evolve point discussion opinion meeting board director monitor board member root corporate governance performance dutie director term legal outside member yukio matsutani outside director compliance soundness management audits inside member ensure effectiveness auditing audit president serve chair committee corporate governance committee meeting platform truly open discussion currently issue supervisory board member system establish transparency consider discussion sustainabilityrelate matter increase audit supervisory board member interview well set separate committee matter concern nomination director employee status business remuneration governance execution review internal consultation document ko sekiguchi outside director important document pertain business execution current structure enable lively exchange opinion believe committee serve promptly receive report execution operation purpose effectively look forward indepth exchange opinion future request statutory auditor office yoshihisa aoki outside director establish assist duty audit supervisory board committee provide outside director opportunity exchange opinion member convene meeting audit supervisory interact individual execute business operate company financial board assist duty audit supervisory board market attention succession plan increase grateful firsthand look different kind leader group business approach leader member independent director authority management operating company mayo mita outside directorcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report governance audit supervisory board member skill matrix remuneration director audit supervisory board member strategic legal basic approach officer remuneration technology healthcare major global planning finance compliance company business rd marketing accounting risk analysis administration qualification companys remuneration plan director audit supervisory board member production public health etc sale management design achieve sustainable growth enhance corporate value medium yozo toba long term group base corporate philosophy ensure function business execution management supervision exercise hiroshi sugawara cpa appropriately maintain transparency fairness kanako osawa attorney remuneration level sachie tsuji cpa consider need acquire motivate outstanding personnel responsibility company global business activity company set remuneration internal audit department level fully commensurate role responsibility expect personnel company internal audit department report directly president department consider level company company consider benchmark base scale industry business model regularly conduct audits base internal audit rule verify operation execute appropriately efficiently regard asset business remuneration system company affiliate company department submit audit report regard remuneration director responsible business execution company president director audit supervisory board member need formulated remuneration system closely link performance individual improvement department recommend remedial action later confirm fiscal year medium long term emphasize sustainable implementation contribute optimization business execution enhancement corporate value remuneration consist fix remuneration basic remuneration performancelinke bonus sharebase payment emphasize link internal control department shareholder value remuneration outside director audit supervisory board member comprise fix remuneration basic remuneration light duty company view internal control integral component corporate governance function compliance risk management establish internal total remuneration director audit supervisory board member control department department charge compliance risk management total total type remuneration million number improve internal control system internal control department promote otsuka remuneration eligible fix performance sharebase group global code business ethic otsuka group global rule otsuka million remuneration link bonus payment officer holding affiliate company work establish promote compliance director program risk management program company status establishment outside director operation program regularly report board director audit supervisory board accounting auditor audit supervisory board member outside audit internal control department handle internal control financial report supervisory board member company affiliate company department formulate rule manual total pertain internal control provide training ensure employee thoroughly outside director understand operational rule department work cooperation internal outside audit supervisory board member audit department continuously monitor status operation basis note director company concurrently serve employee internal control system management personnel reliably evaluate fiscal outside director audit supervisory board member receive total remuneration million company subsidiary service director audit supervisory board memberscontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report governance content remuneration director exclude outside director fiscal year evaluation allotment ratio summary release condition content remuneration director exclude outside director follow allocation time remuneration type pa fy ixm ee dn vt rie bh leod include policy deter mm inu ne gr ta mio inn g c r ce not dition remuneration ie nr ci ue ms b ency st df rth e fisll co ac l yt ee ad r e aa sc th h ey e ea vr lt ua ak ti og n p esi rn iog dle hun ob wjc eo ecn vt ed f ri ti c ho en l syo hef aa rrn e sc su winm ilg lb l nee n f ti c bsy c e ai n rl e yt leeh aae sr e number combine consolidated revenue remuneration director hold company determine base duty condition share consolidated operating profit target responsibility include formulation group strategy monitor group achievement rate operation strengthen corporate governance evaluation period fiscal evaluation period value remuneration director serve concurrently director subsidiary year fiscal fiscal fall value fix cash operating company determine base duty responsibility include series b share cumulative plan remuneration fix e fox mcu ut li ao tn io nf ob fu ss ti rn ae tess g ib ea ss fe od r p eg rr ao tu inp g ctr oa mte pg aie n ie f r nu dl st te red n b gy th ent iu nk ga c h oro pld oi rn ag te ec dh ii uev tee rn mt ns uta mn bd ea rr f ehe aa lr aaa trl il oo noc fa p ee h rd e io p dt e rh ie sd ts ha em te w oim fe l v b e el fu de r iu eo f r tc eo r n mes x p ml eid na st e ae gd e mb ou f e ni hn te e p las h np ir r fit governance remuneration shall exceed upper limit remuneration resolve performance share year fiscal fiscal cumulative actual value shareholder meeting target share consolidated business profit fix remuneration pay equally month ea r ss aa rll oc fa te hd e pt e rh ioe time rd expense evaluation period remuneration pay lump sum certain time fiscal year evaluation period fiscal evaluation period value calculation method determine base rate achievement fiscal year year fiscal fiscal fall value performance cash target consolidated revenue consolidated operating profit consolidated business series c share cumulative link bonus variable p coro nf si ot lb ide afo ter de r p erd fo e rmxp ae nn cs ee r g e p tsr ag nre ds w ait ph p r os pp iac tt e b um sie nd ei su sm mt ao n alo gn eg mt ee nrm n ts ha et msf ea dct iuio mn ef r ns uta mn bd ea rr f ehe aa lr aaa trl il oo noc fa p ee h rd e io p dt e rh ie sd ts ha em te w oim fe l cn ac pan ic tcs aoo l rl ci dd oaa sn tt e c rd e wc ioo ts fht ro hf hec e c p ei vnt aa lol u l idc ta ia ol tc neu pla et d compliance corporate governance individual personal performance cost capital share year fiscal fiscal cumulative actual condition share value consolidate net operate company introduce sharebased payment plan reflect progress year allocate time profit tax evaluation period achieve target mediumterm management plan cover period start period fiscal fiscal note restrict stock allocation agreement conclude grantee stipulate certain case transfer restriction plan restrict stock allocation agreement stipulate condition include restricted stock shall release company shall acquire restrict stock pay compensation noncash transfer restriction set period conclude grantee plan design example sharebase restrict function effective remuneration system combine multiple release condition director company retire end transfer restriction period company shall acquire pay payment stock transfer restriction include set performance evaluation period performance compensation director restrict stock retirement director company recognize variable achievement principle grant restrict stock require evaluation reason completion term office death performance fiscal year time fiscal year director retire end transfer restriction period reason completion term office specifically stock grant fiscal year item require evaluation performance death number share restrict stock release timing release shall reasonably adjust necessary company shall acquire pay compensation share decide transfer restriction single fiscal year time fiscal year evaluation period release item require evaluation performance fiscal year performancebase release condition meet company shall acquire pay compensation share decide transfer restriction release overview noncash remuneration restrict stock determine number share allocate grantee restrict stock standard number share set fiscal year individual give consideration performance duty responsibility weight versus fix remuneration basic remuneration base standard number share share allot series fiscal year time fiscal year evaluation period fiscal composition outside director remuneration year accord specify release condition remuneration outside director comprise fix remuneration variable component base business performance detail late information corporate governance officer remuneration visit composition audit supervisory board member remuneration sustainability section otsuka holding website httpswwwotsukacomencsrgovernanceofficercompensationhtml remuneration audit supervisory board member comprise fix remuneration alternatively refer th annual security report variable component base business performance httpswwwotsukacomjpirlibrarysecuritieshtml available japanesecontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report director audit supervisory board member march directors ichiro tatsuo yoshiro shuichi yuko otsuka higuchi matsuo takagi makino c r dh e irpa ei r cr e tm oea rnn aa tn ivd e p r dr e ie rp es ri ced ts oe en rn ct en oid v e e p dx r ie esc cu tt oeiv n ad ne dp u ty csa onage director e cx fe ocutive director profile profile profile profile profile apr join otsuka pharmaceutical factory inc mar join otsuka pharmaceutical co ltd apr join otsuka pharmaceutical co ltd apr join tobishima corporation apr join otsuka pharmaceutical co ltd jun executive director director consumer product development jun senior manage director otsuka pharmaceutical co ltd pharmavite jan vice president associate general manager general affairs sep join otsuka pharmaceutical co ltd apr join baxter limited division otsuka pharmaceutical co ltd nov executive deputy president executive director otsuka pharmaceutical department otsuka pharmaceutical co ltd aug finance department oiaa division otsuka pharmaceutical co ltd apr join otsuka pharmaceutical co ltd jun managing director responsible consumer product publicity co ltd jun vice president general manager general affairs department jul corporate finance accounting department otsuka pharmaceutical mar director corporate finance accounting department promotion development division otsuka pharmaceutical co ltd jun executive director responsible business otsuka pharmaceutical otsuka pharmaceutical co ltd co ltd otsuka holdings co ltd dec executive director research development otsuka pharmaceutical co ltd nov senior vice president general manager general affairs mar vice president responsible india business otsuka pharmaceutical sep vice president director corporate finance accounting factory inc jun president representative director otsuka pharmaceutical co ltd department additional responsibility legal affair external factory inc department otsuka holdings co ltd representative director otsuka pharmaceutical factory inc jun executive director otsuka pharmaceutical co ltd relations otsuka pharmaceutical co ltd ceo claris otsuka private limited otsuka pharmaceutical india vice president director accounting department otsuka pharmaceutical dec executive deputy president representative director otsuka jul president representative director ceo otsuka holdings co ltd jul manage director corporate administration otsuka holdings co ltd private limited co ltd pharmaceutical factory inc current mar senior manage director corporate administration otsuka holdings jan senior vice president president office otsuka holdings co ltd apr vice president director tax department otsuka holdings co ltd j j ju u ue l n nc p e e rxxr ee ee ps cc ri uud ett se ii v en v e not e td adn e ti pd ir u er c yte p p irr r r e eeos cse tt osn eu rt na k ott av th sne u dod k l ed air xi e n pec g c ht uo r ric v mo e ds c u l ertk e uda c cop arh la fr cua tk oc ae r yu h oi ic nla cl n f vga isc c eco lin tdc f mee abc r e p c cx r h uee rsc riiu r ed not ei tv n e not ad ani nr de c r rt eo epr p r ro e est ses eu n nk taa tic iv veh e e dm ir ri ec eca ctl oc r r tl sut ud k k p ph ha ar rm ac ce eu ut ti ic al l c co l lt td j man ar r c e eex xo e en c ci ou ul rt imv v e ea dnai er g pe uc not tgo r p ri ert e ss c iu dtk ea r n tom eat nsd u di k c raa e l h pd eldv sei ic n ne g ts tc c ivo e l lt rd e c tc ou rr r oen tst u ka mar e e cx x ote es uc c u u lk tt ta di v v pe eh dari ir rme ec cat tco oer ru tf bii c un sa l n ncc eoe pln od r tb fou ls ioin e ms np ao grt ef mol eio n tm oan tsa ug ke lt ing ar r v e ex xi tc e ese u c c u ukp tar ie v vps e ehi dae r r rm e et c c td c oei r rr u e c cc ic fto orplr c oo orof sth uele kt f adf hn aa onn lc dc e ie n g st sa cuc okc ao u lh tn dt l n ig cn u gd rs ecp na tr lte dn chairman representative director otsuka holdings co ltd pharmaceutical co ltd current oct president otsuka america inc current mar executive director finance otsuka pharmaceutical co ltd current mar executive director otsuka pharmaceutical co ltd current executive deputy president director otsuka holdings co ltd current mar manage director business strategy otsuka pharmaceutical co ltd chairman otsuka pharmaceutical factory inc current chairman representative director otsuka holdings co ltd current managing director cso otsuka holdings co ltd current mar representative director otsuka pharmaceutical factory inc current masayuki noriko makoto kobayashi tojo inoue executive director executive director executive director profile profile profile apr join daiwa bank ltd resona bank limited apr join goldman sachs japan corporation apr join otsuka pharmaceutical co ltd oct join taiho pharmaceutical co ltd aug join shearson lehman brothers holdings inc jun vice president general manager diagnostic division otsuka aug president taiho pharma usa inc taiho oncology inc jul engagement manager mckinsey company japan office pharmaceutical co ltd sep executive director taiho pharmaceutical co ltd jun director intel capital japan intel corporation jun senior vice president deputy general manager pharmaceutical business division otsuka pharmaceutical co ltd apr president ceo otsuka america inc aug manage director corporate development otsuka holdings co ltd mar executive director executive vice president general manager apr president representative director taiho pharmaceutical co ltd feb executive director otsuka medical devices co ltd nutraceuticals business division otsuka pharmaceutical co ltd apr e cc x hu e ar cr iue rmn tit v e n ti ihc oto not oih loo g p yh ia nr cm c u urs ra en ti nc ap ur g p exre es ci ud te ivn et dn ird e cc te oo r dts cuk ea pm ar ri mca v tec llc mp ar r e mx ae ncu agti iv ne g dir ie rec cto tor r p nh ua tr rm aca ev uit te ic l al lsc business otsuka pharmaceutical jan president representative director otsuka medical devices co ltd co ltd mar executive director otsuka holdings co ltd current current sep executive director daiya foods inc executive director otsuka america inc mar senior manage director nutraceutical business otsuka pharmaceutical aug chairman pharmavite llc co ltd mar executive director otsuka holdings co ltd current oct chairman nardobel sas mar executive deputy president executive director otsuka pharmaceutical co ltd mar president representative director otsuka pharmaceutical co ltd current executive director otsuka holdings co ltd currentcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report director audit supervisory board member outside directors yukio ko yoshihisa mayo tatsuaki matsutani sekiguchi aoki mita kitachi outside director outside director outside director outside director outside director profile profile profile profile profile apr intern pediatric department st lukes international hospital apr join mitsubishi corporation apr join itochu corporation apr join morgan stanley japan securities co ltd mitsubishi ufj oct join sanwa tokyo marunouchi office audit corporation deloitte oct joined ministry health welfare ministry health labour join boston consulting group jun executive officer itochu corporation morgan stanley securities co ltd touche tohmatsu llc welfare jan general manager sterrad business division johnson johnson apr manage executive officer president food company itochu jan equity research division healthcare morgan stanley japan securities apr register certify public accountant aug directorgeneral health policy bureau ministry health labour medical k k johnson johnson k k medical company corporation co ltd jul partner tohmatsu co deloitte touche tohmatsu llc welfare nov president representative director janssen kyowa co ltd apr member board senior manage executive officer president dec managing director morgan stanley japan securities co ltd apr commissioner public interest corporation commission cabinet office aug director national sanatorium tama zenshoen janssen pharmaceutical kk food company itochu corporation dec senior advisor investment banking business unit healthcare oct leader advisory development division deloitte touche tohmatsu llc apr president national institute public health jul chairman director janssen kyowa co ltd mar administrative officer itochu corporation current mitsubishi ufj morgan stanley securities co ltd nov member board deloitte touche tohmatsu llc dec vice president international university health welfare oct supreme advisor janssen kyowa co ltd jun outside director arata corporation current mar outside director otsuka holdings co ltd current jun leader industry service division advisory service headquarters mar outside director otsuka holdings co ltd current jan representative director dia japan sh dia japan mar outside director otsuka holdings co ltd current deloitte touche tohmatsu llc jun president japan public health association current apr outside director nic corporation solasto corporation jun think leader deloitte tohmatsu llc mar outside director kenedix inc sep special adviser governor kanagawa prefecture current mar outside director otsuka holdings co ltd current mar outside director otsuka holdings co ltd current audit supervisory board member yozo hiroshi kanako sachie tsuji toba sugawara osawa outside audit stand audit outside audit outside audit supervisory board supervisory board supervisory board supervisory board member member member member profile profile profile profile apr join otsuka chemical holding co ltd otsuka chemical co ltd oct join chuo audit corporation apr register attorney law daiichi tokyo bar associationjoine oct join tohmatsu co deloitte touche tohmatsu llc jan director information center otsuka chemical holdings co ltd oct joined deloitte touche tohmatsu deloitte touche tohmatsu llc kajitani law office current apr register certify public accountant jan cfo trocellen gmbh apr register certify public accountant oct admit bar state new york jul representative director splus corporation bizsuppli operate officer information system department otsuka chemical feb vice president capital management co ltd current jun outside director audit supervisory committee member lintec corporation current holdings co ltd otsuka chemical co ltd jun outside audit supervisory board member otsuka holdings co ltd corporation current jun director association certified fraud examiner current jun corporate officer director corporate finance accounting current apr committee member reform collateral law legislative council mar outside director audit supervisory board member sbs holdings department otsuka holdings co ltd jun outside audit supervisory board member otsuka pharmaceutical ministry justice current inc current dec executive director corporate administration accounting otsuka co ltd director japanese association business recovery current jun outside audit supervisory board member shindengen electric chemical co ltd oct outside director nippon parking development co ltd jun external director tpr co ltd current manufacturing co ltd current mar executive vice president corporate finance accounting mar audit supervisory board member otsuka pharmaceutical co ltd mar outside audit supervisory board member otsuka holdings co ltd mar outside audit supervisory board member otsuka holdings co ltd corporate service department otsuka holdings co ltd current current current mar stand audit supervisory board member otsuka holdings co ltd current mar audit supervisory board member otsuka chemical co ltd currentcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report governance awareness survey measure trainee require submit sign declaration compliance observe regulation result train status submission declaration form regularly report meeting board director operational status internal reporting system internal audits group company likewise report example initiative include basic policy appointment compliance officer overseas group company regular meeting share otsuka group seek earn trust stakeholder achieve status progress country asia instance director charge compliance visit sustain growth contribute people health worldwide act company gather information offer suggestion improvement good faith high level ethic accordance corporate philosophy otsukapeople create new product well compliance promotion system health worldwide commitment encapsulate otsuka group global code business ethic outline standard behavior board director expect involve work reinforce range supervise report global policy reflect behavioral standard core area regular training helps ensure compliance stance thoroughly embed risk management committee administer otsuka holding detail global policy compliancerelate internal control department initiative visit website httpswwwotsukacomencsrgovernancecompliancehtml instruct report group company department charge compliance compliance promotion system hold company role maximize group corporate value otsuka holding monitor system establish system appropriate business operation perspective group company internal audit department report directly president department conduct establish system facilitate cooperation otsuka group system group regular audits base internal audit rule verify operation execute appropriately company report otsuka holding necessary item specify affiliate company efficiently regard asset business general otsuka holding otsuka group management regulation obtain approval relevant important item board director company audit report submit president director audit supervisory board build groupwide risk management system include establishment risk management member need improvement department recommend remedial action later committee chair president representative director oversee system operation confirm implementation contribute optimization business execution risk management committee board director receive regular report compliance department share information work cooperation audit supervisory board member risk management action plan result internal control department report accounting auditor plan form basis discussion issue additional measure otsuka group operate crisis management system enable swift cohesive response instill thorough compliance group company otsuka group conduct universal training risk event demand urgent response occur outside japan critical timesensitive base policy otsuka group global code business ethic otsuka group global event occur group company immediately share information main operating anticorruption policy otsuka group global policy conflict interest training material company otsuka holding relevant department mount coordinate response available english french chinese korean indonesian language distribute group mitigate impact otsuka holding maintain update regulation manual documentation company executive employee attend relate training annually depth set fundamental approach risk management response enhance groupwide breadth compliance understanding employee evaluate test training readiness regular training exercisescontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report governance governance tax compliance work maintain improve taxrelated governance recognize contribute enhancement corporate value end strengthen cooperation operate company secure train capable human resource maintain appropriate basic policy system enhance group tax compliance reduce tax risk furthermore establish otsuka group operate world recognize report obligation board director audit supervisory board appropriate payment taxis accordance relevant law mention policy process ongoing implementation maintenance regulation country region contribute local economy country region group complie otsuka group global code business ethic group tax policy countryspecific law risk management regulation tax treaty international taxation rule engage transaction design evade payment taxis carry appropriate filing payment taxis country endeavor appropriately disclose information ensure degree basic policy transparency trust deal tax authority country otsuka group recognize pursue management efficiency globalization business make tax oversight complex control risk inherent business activity important enhance continuously update information consulting tax expert corporate value end vital establish groupwide system necessary appropriately respond order minimize tax risk enable executive employee uncover identify deal risk relate work swiftly otsuka group manage risk initiative outline supervision management correspondence tax authority otsuka group remain committed build constructive relationship tax authority country region operate economy global digital organization economic cooperation development oecd organization review risk management system basic rule international taxation shift system enterprise permanent enhance risk management otsuka holding main operating company facility location liable tax income earn market means process report company introduce enterprise risk management erm july purpose recognize local tax authority complex farreache continue improve assess groupwide risk prioritize allocation resource control significant risk reliability tax datum establish system provide promptly erm define uncertainty major impact ability fulfill corporate philosophy achieve business strategy goal risk establish groupwide transfer pricing policy risk management framework system risk assessment effectively efficiently manage otsuka group calculate transfer price base oecd guideline create significant risk face group framework system perform risk assessment prevention double taxation fair application transfer price tax system identify gauge significant risk face group main operating company determine countrys transfer price tax system make effort ensure proper transaction relate mitigate transfer avoid accept risk develop implement risk management policy party necessary use advance pricing agreement apa obtain aheadof conduct monitoring activity ongoing basis time consensus tax authoritiesgovernance otsuka holding risk management committee oversee group erm committee participate deliberation significant risk report meeting board director formulate monitor implementation policy management significant risk provide instruction support main operating company need board director receive report committee activity issue instruction necessary oversee efficacy group erm structure detail risk management activity risk management system identification significant risk begin share risk awareness senior management interview otsuka holding main operating company topdown approach board director assessment risk control frontline employee bottomup approach enable comprehensively identify risk exist group group company develop risk report supervision risk management instruction risk management policy risk management action plan risk judge significant activity management activity risk regularly monitor review status risk progress action plan risk management committee otsuka holding aggregate visualize significant risk face group company chair president representative director grasp comprehensive understanding exist risk status control group decision status risk management common risk apply group study closely significant risk gather rr ie skp mr ati nn ag g en et na ttus monitor status risk management identify base result process risk management committee assign priority review risk management system significant risk major impact group business financial loss coordination company risk management business continuity pdca initiative visualization group risk identification risk map otsuka holding group significant risk risk category degree impact level control plan check action awareness management review risk risk management status cot miu n pk oa nph ie eo r sl ad ti ng gs awareness r cd se mkhn si pt g ai afi h nc e e ya att co hn f p ao cof tr lr m oc nku eg l pea lat ai ne dn n r r p pic lsi k lk ni v cm sm ei sea n sn aa nb gg da ee aem cd e te n io tn not pv e rao oa vnn gl iu eai rt wa ego se r sao mi n n eg f n aa rf e cn tr pd n ii os dk nri tc sia not r os n workplace risk reassessment risk tcapmi fo eerge puorg elohw eht content otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report otsuka holding main operating company develop implement countermeasure significant risk base characteristic risk tolerance otsuka holding provide necessary guidance support group company submit report seek advice otsuka holding appropriate activity group coordinate closely promote practice erm otsuka holding group company work prevent risk realize regularly monitor confirm respective tolerance level major risk require risk require prioritize regular groupwide strengthen monitor groupwide control risk risk certain level additional action plan control implement achieve operating company minor level risk high control lowcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report governance significant risk detail business risk visit website groupwide risk assessment otsuka group recognize follow significant risk httpswwwotsukacomenirmanagementriskhtml otsuka holding main operating company take step mitigate item risk scenario response risk management policy pharmaceutical business healthcare revision drug price standard lower drug price om nio tn os rt inra gt ng ah ne v la yzlu ine g af dn mew d str ru ag ts va en td r ep nr svide product appropriate price c core pti ng v wa hlu ile e ms aa nto tata inl ih ne ga alt h hc ea ar le th risk cost containment measure encouragement use generic drug biosimilar create value total healthcare company appetite delay cancellation rd enhance pipeline priority area op fh na erm w dc uu gt dca el v eb lu os pin ess n uncertainty reduction exclusive license period expand range development item e hv ee al lo tp hi yn rg n ke aw p pd er tu ig tes maintain significant emergence compete product proper portfolio management appropriate review rd policy bri usk sis n en sc ore pharmaceutical business effect suspension sale recall effect e es st ta ab bl li sh hi ng g sa ysf te et foa rn ia mg pe lm emen et n tt ir nu gc su ar fe e yin mcl eu ad si un rg e c inll e ac ct cio rd nd ce e wva il tu ha tt hio en r eo gf usa laf te oy n sn ofo f r em aca hti con untry region r ad nu ac gin eg r ei nsk b sty r ust cr te un regthene safety area inn tu ot r na ec weu ct aic ta el g b ou ris ein e ns e rx ep ga ion nsi son f c da h ei tlu enr rge ioe rs f io r ao nnd odu f c ett rs ce ot ng oa md hd e icnr e cin oss g n c dou ts l oo e nm g sa e l pr r e lse te r d cc li inn ss tability repo lt en vmit ao nzr tii n n dgg e pa ra rd tt mea gn eya n l tfy srz cin og pm eloa rancr tgo ta gen r omd n p eei fc frr eso p c tet ir vce ein v d nes fb oa rmse ad io n p cr oo lld eu cc tit nn ad n l c aa nl ac lh ya sir sa c ne dri st ti rc tegize c r ae pr ge pa eot tni tsg e w v ha il lu ee ne taw c ia not ge g ao hr eie l ta hn yd r isk p qn r uou adt lr iu ta ycc te su bt uic sa inl eb su ss n foe oss sn ad fe c n nu dm er q cau ua sl eit dy bp yr qb ul ae lm itys ce ng r oco l sn yt sa tm emin fati io lun r eby hazardous substance e c nqs gu u ii nitg gio c qno u lp d tl yi mac ie pn rw oe vi not eh nle c eeg n sl f c hn e rd r ot ur ife gig c hau al ia uot dno isr sa n r ee tq ciu ni tr ee rm nae tn os n aa ln sd ag dv ae rr dn smental industry standard r r se ae l fd eu te yc sg ur qi rs auk na b cli ey ys mre ng gh ee mni en ng ay nst de ms cua nl lde tu n u rt n e r e aec nrr dsu ct onm rd pe ont rg tn efd c p od hre ip lv ooe srl oo ptp e hm yent f fsta ari ial lu uter eg yt de ec vu er le psu tf af li eci ne tnt human resource execute highlevel pd mti tic ina gti dn iv en rsd e bv ae sl eo dp n tht eo f f tu sutu kr ae gg ue pr gt li oo bn lo cf om da en oa fg um se inn et h u em tha icn r ae nso du prc os v iv dia g rs eu lk ea va g nl sb ya sl ea mca ae nm mechanism r ree sd ou uc ri cn eg r eis vk e lb oy p mtr ee nn tg gth roe un pin wg ih du eman building structure eg establish committee address environmental issue pre ola le mn saction response resolution environmental establish otsuka group environmental policy environmental activity guideline promote action address issue reduce risk proactively address environmental issue f ga hil gu r ee sm ioe ne st group environmental target eg cut p mu ar nsu ai gn eg e ef nfi tc se yn stt e mn sd highly effective action acquisition iso integrate certification environmental e bn uv sii nro en ssmental issue pursue action cut ghg emission business value chain base establishment clear target supply chain transparency riga hjo tsr n lao bn oc ro tm hep l eia nn vc ire nr ei ns tc cn od ru ruct p te iog n ir ne l ta ht ein sg u pto p lh yu cm haa n e c es sot tna adb bul li ics sh htii inn ngg g dt ah u ne e nit gls ogu iek nna gc g e r will ou nhp ie n op rr io e nc l geu c sr ye snm tg ee mn sut pp po ii ec ry otsuka group sustainable procurement guideline r pee old se tu c sc ei nn lg eg c tr u ii os pk np l mh ier oro nu iag tonh rd ie n ov ga n l ogu foa sit n uio g pn ps l iw erh sen failure appropriately allocate business resource strategic allocation managerial resource priority segment important measure business reduce risk strengthen risk hold company nc suo fm fip cil ee nte vw er ro nn ag n cf eo r bm u hl oa lt dio inn g cr r mev pie aw ny n g clr uo du ip n gst gra rt oe ug py e gs lota bb al li ph oin lig ci ea groupwide oversight mechanism base otsuka group global code business ethic respective c ao dp oe nra gt oio inn g rm eio nn fog r g cero mu ep n tc om f gp ra uie ps company management strengthen internal monitoring framework establish groupwide internal reporting system company management system c reo pr ar ta oe n brand management insufficient corporate brand development management e f eos dt r ua cb aul ti ls ia oh ni n ag g n dh h e e tr c aoi nm iu na k gn f ogg r em u xe p en c p ut r tc vo g em u si ae nit l dt ine eee ms ployee r syne sd teu e mc si tn sag b lr ii ss hk nth gr inu fg oh rm tg ioo nin cg llr ea ci tn ii ng failure generate synergy insufficient diligence rii sg kn si f ci oc man mt business alliance acquisition p fn oa lr u lt ofn wfe ic ir nis e g n ar na b c u aq cu qni ur ee sd ic oo nm nap ga en mie es not engage alliance c sto rn od nu gc et ri n bg u sc ia nr ee sf su ml ou ne oi rl ii ng ge n wc e nf eta nr gg ae gt nco gm inp ni e ia nd c ea os fos llowe acquisition r ane du mci ng tr ois rk b gy ss yt sr te en mg sthene screening business area digitalization die gc il ti le iz ic oo nmpetitive ability slow insufficient imd po rp ot vin ing g lt ia tete rao cf ah ne sr kt lt le c gh rn oo ul po g wie ids e c hn rd ou uc gt hin sg e mpr io arf af nc nc fe op rt ae tm ioo nn ss ht ara rit nio gns practical application r lae td eu stc tn eg ch r nis ok l ob gy ep sr aa nc dt ove ffl ey ra ind p trt ing nth ge natural disaster pandemic nnu ats tep ure rr aun lps dto ion san tof e rp r dl oa e rn l p ao np de f er pa mrt oi io cdn c e dt ec v e l lo os ps mof e nh tu dua en tr oe mo au jr oce r f c hor onm rd ou u ul gtt hnin g ig r b e pgu leus mi ln ee r n ds r ac nai n n odu f et cy x ep vrl idin se pc rlu evd ein ng ti oo nn g mo ein ag su r ev siew improvement r b kee ed sa pu not ic e nei sn r gs g ecc mei nns pk ta li r onb yuoy e isi en ya sc n po d nlr fp p n oo n rr n mia ndt egi e dn g ai ncn da nu tr oa l supply stability gle os bta ab l eli cz oa not oio mn co f tm aga nte ar ti ia ol n p oro r c hu er ie gm hte en not e dn gd e ou pp op iy ti cc aa lu rs ie sd k e ses v e ub r rs il ni f gh ic pg po rnn ph f ro ipu ar ee c iu not ra ven emd na te nd rt ys ab na u ds c sed ps ro en c rg m n g p pa u rn l otd di pg ule cd p ou npt p l cid oa rs sr sd ms n ud l ts ie pc lu e r min ag n ul ft ae cr tn ua rt ii nv ge sr ia tw es materials r sc ee e cd n uu rc ir ni gg r ldi ts ek v nb r ay si fr iy vu en n n rg ai n wug p v pa alr tei eo r rsu l snd patent infringement pnh rf oi rr pid n e g rp e ta ymr rt ey ign hn tf b sr yin tg em oe tn sut ko af gn rt oe ull pe c ot fu ta hl ip rdro pp ae rr tt yy ir nig teh lt ls ectual e st ia nb gl dsh atin ag b aa em na dg em rt c ha n ad g em cn ieit tr oin cg nsy ds ut ce tm ef ao rr c hn et se l ale nc dt u coal l lp ecro p ine fr oty rm ri ag th iot n r ad nu ac gin eg r ei nsk b dst mre ng th oe rin ni gn g ystem litigation l init si ug fa ft icio ien n b r lio tu igg ah tt io b ny ra e st ph oir nd eparty e cs ot oa pb eli rs ah ti og n wn tin ht oe urn tsa il r ee p coo urt nin seg l en td c cooperation system r sye sd teu mcin g nr dis k tb rey n e gs tt hab enli inh gin cg pt ee rr ta il n major system outage establish otsuka group global information security policy information management external cyberattack education training executive employee r lee vd eu lsc n og n gr ois ik n gth ir mou pg roh v h emig eh ne tr e ac nu dri ty falsification misuse leakage datum negligence etc establish group information security committee employee training employee contractor thirdparty establish emergency response system center internal computer security incident response team csirt failure legal restriction country cooperation relevant department implement appropriate management business operation base local operating reduce risk establish system global business operation group operate environment cooperation operating company sudden change economic condition business environment optimize strategy longterm perspective base product local characteristic relevant departmentscontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report financial nonfinancial highlight profit attributable owner company return revenue overseas revenue ratio business profit business profit margin ratio revenue equity attributable owner company roe revenue overseas revenue ratio business profit business profit margin profit attributable owner company return equity attributable owner company roe billion billion billion plan plan plan revenue leave overseas revenue ratio right business profit leave business profit margin right profit attributable owner company leave return equity attributable owner company roe right pharmaceutical business total asset ratio equity attributable rd expense rd ratio ratio revenue owner company total asset annual dividend share dividend payout ratio rd expense pharmaceutical business total asset annual dividend share billion billion plan plan rd expense leave total asset leave annual dividend share leave rd ratio right ratio equity attributable owner company total asset right dividend payout ratio right exclude impairment lossescontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report financial nonfinancial highlight visit otsuka holding website key sustainability data httpswwwotsukacomencsrdata nunmubmerb oef mofp leomyepesloyee nunmubmerb oef rf eomf aflee mmaanlea gmerasn faegmearlse mfeanmaageler rmataionager ratio emnpulomyebee rta okfin egm paprleonytael elesa tveake parental leave outside japan japan number female manager leave female manager ratio right female male scope production site consolidate otsuka group scope fiscal company otsuka pharmaceutical otsuka pharmaceutical factory taiho scope fiscal company otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical otsuka warehouse otsuka chemical otsuka food pharmaceutical otsuka warehouse otsuka chemical otsuka food fiscal company company plus otsuka pharmaceutical development fiscal company company plus otsuka pharmaceutical development commercialization otsuka america pharmaceutical pharmavite commercialization otsuka america pharmaceutical pharmavite fiscal company company plus otsuka holding otsuka medical device fiscal company company plus otsuka holding otsuka medical device fiscal nineteen company company plus otsuka electronic otsuka techno fiscal nineteen company company plus otsuka electronic otsuka techno okayama taiho pharmaceutical otsuka packaging industry otsuka ohmi ceramics higashiyama film okayama taiho pharmaceutical otsuka packaging industry otsuka ohmi ceramics higashiyama film otsuka wellness vend jimro otsuka wellness vend jimro simple incineration landfill volume totcaol c oem eimssiisosinonss co emission sale wawtear tuesra guesa wgaete wr uastee erf fiucsieangcey sale tottaol twaal swte avostluem veolume thousand tonsco ton million thousand million ton ton japan indonesia japan india southeast asia south korea east asia south asia north america north africa china north america europe south america europe total co emission leave co emission sale right water usage leave water usage sale right simple incineration landfill leave total waste volume right scope production site consolidate otsuka group scope production site consolidate otsuka group scope production site consolidate otsuka groupcontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report esg content index addition information include integrate report otsuka group disclose follow esgrelated information website visit website detail item policy commitment system initiative overall signatory united nations global compact sustainability mission materiality goal progress stakeholder engagement sustainability management structure external recognition datum people environment governance society health basic policy page pharmaceutical basic policy contribution unmet medical need page business goal progress initiative access medicine fy goal quantification fy progress initiative infectious disease include tuberculosis page nutraceutical basic policy catering yettobeimagine need business goal progress initiative access nutrition people basic policy human resource basic policy human resource development program include management human resource development program development internship program system leverage ability open recruiting system selfassessment system etc diversity otsuka group global code business ethic diversity inclusion system diversity promotion include mindset establish structure help diverse human resource play active role regardless inclusion basic policy nationality race age gender disability sexual orientation etc signatory women empowerment principle wep example external recognition ikuboss manager supportive worklife balance declaration group companies health safety otsuka group global code business ethic initiative employee health maintenance promotion human right labor standard employee health initiative workplace health safety basic policy initiative reduction overtime encourage employee pay leave declaration health group company example external recognition health safety committee promotion structure fair employment otsuka group global code business ethic internal training bully harassment issue work human right labor standard discrimination harassment reporting concern employee survey improvement activity base survey result condition basic policy human right otsuka group global code business ethic implement human right risk assessment identify salient human right risk initiative human right labor standard discrimination harassment reporting concern identify salient human right issue implement corrective measure basic policy whistleblowe hotline otsuka group human right policy employee train otsuka group human right policy promotional structure external collaboration quality basic policy otsuka group global code business ethic business integrity maintain book record etc certification status iso quality iso fssc food safety etc research commitment rd compliance law guideline ethical consideration etc ethical consideration research involve animal development ethical consideration research involve humanderive specimen ethical consideration research involve pathogenic microorganism pathogen etc genetically modify organism ethic clinical trial compliance rd otsuka group company management public research fund procurement basic policy page promotion sustainable procurement consideration environment human right matter otsuka group procurement policy page include diligence investigation new supplier common saq briefing session supplier page otsuka group sustainable procurement guideline page joint business collaborator audit pharmaceutical company sustainable procurement promotional structure establishment otsuka sustainable procurement global initiative streamline production supply product task force goal progress page production basic policy page production quality control patientcustomer safety compliance regulatory requirement governmental industry quality control measure include global product quality policy pharmaceutical product nc global standard page patient quality policy nutraceutical business otsuka pharmaceutical acquisition iso quality iso fssc food safety etc promotion structure include global production meeting global product quality meeting quality control base gqp gvp postmarkete safety management customer safety global implementation pharmacovigilance activity page measure falsify medicine employee training logistic basic policy initiative quality control maintenance promotion logistic compliance good distribution practice gdp guideline establishment gdp promotion office promotion structure control maintenance employee training etc product quality stable supply logistic initiative streamline cooperation shipper distributor standardization itbase data system digitization form etc initiative stable supply distribution strage inventory registration vehicle authorize access restrict area etc environmentally friendly measure promotion modal shift reduce co emission etccontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report esg content index esg balance sheet find website httpswwwotsukacomencsresgcontrolcharthtml item policy commitment system initiative sale basic policy conduct appropriate marketing promotion activity compliance law regulation marketing establish internal code practice expand jpmas promotion code prescription gathering disseminate information product relate knowledge late academic information etc drug activity target healthcare professional employee train structural measure establish scientific affair department gathering reduce food loss extend shelf life switch monthbase expiration date etc disseminate information product relate knowledge late academic information dedicated review unit ensure appropriate marketing promotion activity customer basic policy promote consumeroriente management service declaration consumeroriente commitment ensure appropriate communication customer page groupwide customer service liaison meeting crossdepartment listen customer feedback improve product base customer feedback page meet promotion structure consumeroriente management establish dedicated contact point patient healthcare professional customer environment environmental otsuka group global code business ethic environmental protection management otsuka group environmental policy otsuka group environmental activity guideline group promotional structure center otsuka group global environmental council disclosure iso certification status environmental vision net zero carbon basic policy initiative efficient energy use co reduction expand use renewable energy source introduction cofree neutrality goal progress electricity include solar power generation inhouse consumption purchase green power certificate etc disclosure accord tcfd recommendation disclosure co emission datum page circular basic policy initiative achieve zero waste economy goal progress initiative plastic recycling disclosure waste volume effective use volume final disposal volume datum water basic policy water risk evaluation manufacturing site neutrality goal progress disclosure water usage unit sale datum page governance corporate basic policy governance corporate governance guideline governance basic policy disclosure corporate governance report structure overview governance structure timeline initiative strengthen corporate governance board director audit supervisory board corporate governance committee rationale selection director evaluation board effectiveness skill matrix director audit supervisory board member page succession plan remuneration basic policy disclosure corporate governance report director remuneration standard system method determination audit supervisory board member compliance overall basic policy compliance promotion structure tax compliance basic policy correspondence tax authority tax policy governance transfer pricing policy anticorruption promotion system diligence otsuka group global code business ethic bribery corruption etc training employee otsuka group global anticorruption policy monitoring conflict promotion system training employee interest otsuka group global code business ethic conflict interest etc monitor otsuka group global policy conflict interest protect otsuka group global code business ethic privacy confidentiality etc training employee privacy otsuka group global privacy policy monitoring whistleblowe provision internal external whistleblowing hotline hotline risk overall basic policy identify significant risk risk assessment mitigate risk management risk management policy business continuity planning management enterprise risk management risk management training risk management system initiative mitigate information security risk contribution community policy contribution communitiescontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report main datum effect fiscal end december otsuka adopt international financial reporting standard ifrs information fiscal end december present line ifrs jgaap item unit result operation revenue billion sell general administrative expense billion business profit rd expense billion ratio business profit rd expense revenue rd expense billion rd ratio business profit billion business profit margin operate profit billion operating profit margin profit attributable owner company billion financial position total asset billion total equity billion ratio equity attributable owner company total asset roe cash flow net cash flow operating activity billion net cash flow investing activity billion free cash flow billion dividend annual dividend share yen dividend payout ratio common stock stock price thousand number share outstanding yearend share stock price yearend yen number employee total person japan person outside japan person line item base ifrs change consolidate fiscal year fiscal end december transitional period sga expense jgaap present total expense rd expense company believe cover month april december information useful investor compare company financial result jgaap ifrs december company finalize provisional accounting treatment business combination exclude impairment loss reflect presentation figure year end december business profit revenue cost sale sell general administrative expense share profit associate calculate rd expense number employee include otsuka holding co ltd subsidiariescontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report main datum ifrs item unit unit result operation revenue billion million sell general administrative expense billion million business profit rd expense billion million ratio business profit rd expense revenue rd expense billion million rd ratio business profit billion million business profit margin operate profit billion million operate profit margin profit attributable owner company billion million financial position total asset billion million total equity billion million ratio equity attributable owner company total asset roe cash flow net cash flow operating activity billion million net cash flow investing activity billion million free cash flow billion million dividend annual dividend share yen dividend payout ratio common stock stock price thousand thousand number share outstanding yearend share share stock price yearend yen number employee total person person japan person person outside japan person person content otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report group structure global network corporate information corporate information december otsuka group corporate philosophy company otsuka holdings co ltd establish july overview otsuka group company origin date aim contribute health people world aim main pillar pharmaceutical business diagnosis treatment disease nutraceutical business capital billion support maintenance promotion everyday health company culture summarize word ryukangodo sweat recognize way jissho actualization sozosei creativity foster successive otsuka leader emphasize employee group company country region strive create market unique product service head office kandatsukasamachi chiyodaku tokyo nutraceutical nutritionpharmaceutical end december otsuka holding subsidiary affiliate japan organizational structure otsuka holdings tokyo shinagawa grand central tower konan headquarters minatoku tokyo japan otsuka otsuka pharmaceutical taiho otsuka medical otsuka warehouse otsuka chemical otsuka food pharmaceutical factory pharmaceutical device telephone number global network consolidated employee december europe business control management relate activity company description respect company subsidiary affiliate operate pharmaceutical nutraceutical consumer product business north japan america otsuka operate middla es eia st etc company company countriesregion company south group companiess central america oceania companies company company organization overview main operating company company organization otsuka pharmaceutical total healthcare company support wellbee body co ltd treatment disease promotion everyday health april corporate philosophy otsukapeople create new product well health worldwide otsuka pharmaceutical operate core business benefit people health pharmaceutical business provide new pharmaceutical treatment disease nutraceutical business provide product help people maintain improve health otsuka pharmaceutical original company otsuka group leader iv solutions factory inc japan year experience field base management vision good partner clinical nutrition otsuka pharmaceutical factory create innovative product meet variety need include pharmaceutical medical device oral rehydration solution medical food otc pharmaceutical company operate globally focus japan rest asia taiho pharmaceutical half century work field oncology patient people worldwide co ltd taiho pharmaceutical rddriven specialty pharma focus field oncology allergy immunology urology corporate philosophy strive improve human health contribute society enrich smile oncology field particular taiho pharmaceutical know lead company japan actively promote globalization consumer healthcare business taiho pharmaceutical strive create product support love affluent lifestyle people need utmost priority otsuka warehouse contribute people health worldwide field logistics co ltd found otsuka warehouse develop business emphasis pharmaceutical food product logistic include construct share platform tailor otsuka group business domainspharmaceutical food beverage daily necessitiesand provide optimal logistic solution joint distribution external manufacturer recent year otsuka warehouse utilize achieve connect logistic work reform distribution solution otsuka chemical otsuka chemical creatively give shape power material customer co ltd material core operation otsuka chemical aim continuous technological innovation lead creation product enable high standard live otsuka chemical provide product global market automotive electrical electronic equipment housing healthcare area main segment hydrazine business inorganic composite material business pharmaceutical intermediate active pharmaceutical ingredient api business otsuka food co ltd deliver revolutionary product new dietary style otsuka food motto company begin people food begin spirit mind otsuka food bring spirit food focus deliciousness safety peace mind well health company business food health main theme company strive create propose revolutionary product meet social need aim bring people joy happiness come good health otsuka food seeks achieve sustainable growth contribute society otsuka medical device develop innovative treatment method create new value co ltd establishment february otsuka medical device focus develop unique solution improve health wellbeing patient medical need condition fulfil exist treatment method achieve aspiration pioneer medical device industry company combine global rd effort technology drug discovery knowhow inherent otsuka group heritage base otsuka group corporate philosophyotsukapeople create new product well health worldwideotsuka medical device take offer patient new innovative treatment choice contribute health healthcare people world gniteem sredloherah srotcerid fo draob namriahc tnediserp content otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report internal control department internal audit department nutraceutical business global strategy planning headquarters corporate planning department business insight analytics department cfo planning headquarters finance accounting department tax department corporate service department business development department investor relations department administration department president office public relations department sustainability promotion department human resource department corporate pension office human resource planning department planning department gxp support center legal affair department statutory auditor board statutory statutory auditor office auditorscontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report disclosure otsuka group otsuka group provide overview financial nonfinancial information integrate report integrate report begin fiscal edition otsuka holding visit otsuka holding website additional information include consolidated financial statement financial combine annual report csr report single integrate result presentation supplementary document information research development report bring financial information nonfinancial information hope deepen stakeholder understand group aim indispensable contributor people website otsuka group sustainability health worldwide httpswwwotsukacoman httpswwwotsukacomencsr reporting period fiscal january december note certain information january onward include scope reporting principle report cover otsuka holding co ltd subsidiarie scope activity datum narrow detail note guideline reference international integrate reporting framework international integrate reporting council iirc gri sustainability reporting standard global reporting initiative gri iso environmental reporting guideline ministry environment guidance collaborative value creation ministry economy trade industry guideline investor relation library precaution forwardlooke statement httpswwwotsukacomencsrlibrary httpswwwotsukacomenir integrate report summarize operate financial result otsuka group otsuka holdings co ltd subsidiaries sustainability handbook fiscal january december report handbook present example contain forwardlooke statement forecast pertaining plan stance initiative respect projection strategy performance otsuka group sustainability easily accessible format general public company statement base current analysis belief light information available issue date report actual result differ risk uncertainty affect otsuka group operation medical information environmental report integrate report sake readability unify brand compile publish detailed product different brand name different environmental report introduce otsuka group environmental initiative country region product available country available different brand name different indication different dosage strength note information pharmaceutical product include product development intend advertising promotional purpose medical advicecontent otsukas value creation message ceo create value fact datum otsuka holdings co ltd integrate report stock information december number share authorize share principal shareholder maximumminimum stock price volatility year n nu um mb er r f sh ha ar es h ois ls du ee rd share shareholder sn h thu om ub e ahr ne dldf sh ra ar te ioho l di ng fiscal stom cka x pim ricu em stom ckin pim ricu em stav ndo ala rt dil dt ey v ion master trust bank japan ltd trust account nomura trust banking co ltd stock distribution otsuka founder shareholde fund trust account treasury share security otsuka estate co ltd companies custody bank japan ltd trust account company otsuka group employee shareholding fund financial institutions awa bank ltd jp morgan chase bank jp morgan chase bank smbc nikko securities inc total shareholder return individual foreign otsuka asset co ltd corporation note number share hold rounded nearest thousand fiscal lthough company hold share treasury share exclude list hareholding ratio calculate treasury share deduct otsuka holding comparison topix total return index stock performance stock price leave trading volume right thousand share